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“Would you tell me, please, which way I ought to go from here?" 
"That depends a good deal on where you want to get to," said the Cat. 
"I don’t much care where--" said Alice. 
"Then it doesn’t matter which way you go," said the Cat. 
"So long as I get SOMEWHERE," Alice added as an explanation. 
"Oh, you’re sure to do that," said the Cat, "if you only walk long enough.”  
 
Lewis Carroll, Alice's Adventures in Wonderland  
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Abstract 
 
 
Osteoarthritis (OA) is a common, debilitating disease, involving degeneration 
of cartilage and bone in synovial joints. Subtle changes in the molecular 
structure of subchondral bone matrix occur and may precede gross 
morphological changes in the osteoarthritic joint.  
 
In this thesis, the analytical technique Raman Spectroscopy (which uses a 
monochromatic light source to probe chemical composition) is used to explore 
the hypothesis that subchondral bone changes occur prior to and during joint 
degeneration.  
 
The question is approached by looking at excised tibial plateaus from patients 
undergoing total knee replacement for advanced OA of the knee and comparing 
them with tibial plateaus from healthy joints. The samples were analysed with 
Raman spectroscopy, peripheral quantitative computed tomography (pQCT) 
and chemical analysis, to compare collagen alpha chains. 
 
The results show that bone matrix changes, related to OA, can be detected in 
the subchondral bone prior to overt cartilage damage, by Raman spectroscopy. 
These data provide support that chemical changes in bone can be related to the 
initiation of, or predisposition towards, joint degeneration.  The results 
demonstrate that Raman spectroscopy should be further developed as a future 
tool to provide screening for early detection of joint degeneration based on 
correlating molecular-specific modifications in the subchondral bone. 
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Abbreviations, Conventions and Formulae 
 
Abbreviations 
 
NCP Non-Collagenous Protein 
OA Osteoarthritis 
MMP Matrix MetalloProteinase 
TGF-β Transforming Growth Factor – beta 
TIMP Tissue Inhibitors of Matrix MetalloProteinase 
CT Computed Tomography 
pQCT peripheral Quantitative Computed Tomography 
DXA Dual energy X-ray Absorptiometry 
MRI Magnetic Resonance Imaging 
µMR Magnetic Resonance Microscopy 
PET Positron Emission Tomography 
AFM Atomic Force Microscopy 
EM Electron Microscopy 
DNA Deoxyribonucleic Acid 
RNA Ribonucleic Acid 
CCD Charged Coupled Device 
SORS Spatially Offset Raman Spectroscopy 
iSORS inverse Spatially Offset Raman Spectroscopy 
PCA Principal Component Analysis 
PC Principal Component 
LDA Linear Discriminant Analysis 
SDS PAGE Sodium Dodecyl Sulphate PolyAcrylamide Gel 
  Electrophoresis  
vBMD  volumetric Bone Mineral Density 
aBMD  area Bone Mineral Density 
QA  Quality Assurance 
EDTA  EthyleneDiamineTetraAcetic acid 
LWD  Long Working Distance 
IQR  Inter-Quartile Range 
SD  Standard Deviation  
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Formulae 
 
1. Stress = Force/Area 
 
2. Strain = (Elongated length-Original length)/Original length  
 
3. Young’s Modulus of Elasticity stress/strain (N/m2) 
 
4. General Form of PCA model: 
  
 X=TPT+E 
 
where X matrix is decomposed by PCA into two smaller matrices, one of 
scores T and other of loadings P 
 
 
 
 
where ta and tb are the ath and bth columns of T matrix, respectively 
 
 
 
 
where pa and pb are the ath and bth rows of P matrix, respectively 
 
  
380 P. MOBILI et al.
Raman spectra were acquired via GRAMS software (ver-
sion 3.04, Thermo Galactic, USA). Multivariate data anal-
ysis and pre-processing of data were performed on the Ra-
man spectra, using Origin (version 6.0, MicrocalTM , USA)
and The UnscramblerTM software (version 8.0, CAMO, Nor-
way).
2.3. Multivariate methods
Principal component analysis (PCA) and partial least square-
discriminant analysis (PLS-DA) were performed over the
pre-processed Raman spectra in order to evaluate
(a) the spectral differences among species of microorgan-
isms in the PC space and
(b) to develop models allowing discrimination and classi-
fication among species.
2.3.1. Principal component analysis (PCA)
PCA is a multivariate technique that operates in an unsuper-
vised manner and is used to analyze the inherent structure of
the data. PCA reduces the dimensionality of the data set by
finding an alternative set of coordinates, the principal com-
ponents (PC’s) [18,19]. The general form of PCA model is:
X = TPT + E (1)
whereX matrix is decomposed by PCA into two smaller ma-
trices, one of scores (T ) and other f loadings (P ).
PC’s correspond to a linear combination of the original
variables, which are orthogonal to each other and designed in
such a way that each one successively accounts for the maxi-
mum variability of the data set.
In other words, PCA involves a mathematical procedure
that transforms a large number of correlated variables (i.e.
Raman shifts) into a small r number of uncorrelated variables
called principal components. Numerically this means that
IX
i=1
tiatib = 0 (2)
where ta and tb are the ath and bth columns of T matrix,
respectively, and
IX
i=1
piapib = 0 (3)
where pa and pb are the ath and bth rows of P matrix, respec-
tively.
The first principal component (PC1) accounts for as much
of the variability in the data as possible, and each succeeding
component accounts for as much of the remaining variability
as possible.
When PC-Scores are plotted, for example PC1 vs PC2 or
any combination of the PC’s, they can reveal relationships be-
tween samples (grouping). It is important to remember that
PCA does not act in a supervised manner, meaning that each
number of the groups under study is not known a priori. PCA
provides insight into the percentage of variance explained by
each PC and how many PCs should be kept to maintain the
maximum information from the original data without adding
noise to the current information [18,19]. In addition, when
the PC-loadings are plotted as a function of the variables,
the plot reveals the most important diagnostic variables or
regions related with the differences founded in the data set.
2.3.2. Partial least square-discriminant analysis (PLS-DA)
PLS-DA is a version of PLS in which one or several Y-
variables are modeled simultaneously, thus taking advantage
of possible correlations or colinearity between Y-variables.
In PLS, the response matrix X is decomposed in a fashion
similar to PCA, generating a matrix of scores, T, and load-
ings factors, P. (these vectors can also be referred to as basis
vectors)
X = TPT + E (4)
A similar analysis is performed for Y, producing a matrix
of scores, U, and loadings, Q.
Y = UQT + F (5)
The goal of PLS is to model all the constituents forming
X and Y so that the residuals for X block, E, and the residu-
als for Y block, F, are approximately equal to zero. An inner
relationship is also constructed that relates the scores of X
block to the scores of the Y block.
U = TW (6)
The bove model is improved by developing the so-called
inner relationship. Because latent (basis) vectors are calcu-
lated for both blocks independently, they may have only a
weak relation to each other. The inner relation is improved
by exchanging the scores, T andU, in an iterative calculation.
This allows information from one block to be used to adjust
the orientation of the latent vectors in the other block, and
vice versa. An explanation of the iterative method is avail-
able in the literature [29-31]. Once the complete model is
calculated, the above equations can be combined to give a
matrix of regression vectors, one for each component in Y:
Bˆ = P (PTP )°1WQT (7)
Yˆ = XBˆ (8)
For a discriminant analysis approach, it is assumed that a
sample has to be a member of one of the classes included in
the analysis. Each class is represented by an indicator vari-
able, that is, a binary variable with a value of 1 for members
of the class and 0 for nonmembers. This way, by building
Rev. Mex. Fı´s. 56 (5) (2010) 378–385
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Conventions 
 
Raman Spectra – only Stokes shifted spectra are shown. They are 
plotted with shift (in wavenumber) increasing from left to right. 
 
The terms “normal” and “control” when referring to specimens is used 
interchangeably throughout this thesis; “fresh” refers to control samples 
acquired directly from the operating theatre from living subjects, 
whereas “cadaveric” refers to control samples acquired from cadavers. 
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CHAPTER 1 – INTRODUCTION  
 
1.0 Overview 
The goal of this thesis is to examine the chemical composition and 
molecular structure of components in subchondral bone. Early-stage 
osteoarthritis is characterized by chemical structure changes to 
extracellular matrix macromolecules, many of which have not been 
reliably measured by current histology, imaging or clinical methods. 
These subtle, inherent changes that occur in subchondral bone will 
provide the markers for diagnosis of knee joint damage. We propose to 
develop Raman spectroscopy techniques to examine molecular 
structure and chemical composition of subchondral bone. We further 
propose that Raman spectroscopy will complement current strategies for 
imaging subchondral bone by providing insight into the chemistry of joint 
degeneration. 
 
1.1 Composition of Bone Material 
Bone material (connective tissue composed of cells and 
extracellular matrix) has remarkable mechanical properties and the 
structures made from it (bones/skeleton) remain rigid even after being 
subjected to many thousands of cycles of immense force e.g. for a 70 kg 
individual, the head of the femur experiences a force of over 1600 N 
(≈350 lb) or 2.4 times the body weight during normal walking(Currey 
2006). Bone is able to sustain these immense forces repeatedly 
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because it is a composite material with two phases that both contribute 
to its performance; they are a fibrous scaffold of collagen fibrils (which 
give the material its toughness) and a stiff solid matrix of tiny 
hydroxyapatite crystals (which give the bone material its 
stiffness)(Currey 2006). 
 
1.1.1 Collagen 
The organic scaffold of bone consists of the fibrillar protein 
collagen; it is secreted along other non-collagenous proteins by bone 
cells, becomes mineralised and develops as bone material(Boivin 
2002). Collagen type I, which accounts for 95% of the collagen in bone 
is coded as three polypeptide chains; two identical peptide chains (α1 
chains) and one other similar peptide chain (α2 chain)(Viguet-Carrin 
2006). One end of each alpha chain terminates in an amino functional 
group (-NH2) group and the other end terminates in a carboxyl group (-
COOH)(Veis 1997). In humans, the COL1A1 and COL1A2 chains, are 
encoded by genes on chromosome 17 and 7, respectively(Huerre 
1982). Each chain is roughly 1000 amino acids long and consists of a 
repetitive triplet pattern defined by the presence of glycine (Gly) at every 
third position, along most of its length(Glanville 1983). Usually the 
second (X) and often the third position in the collagen triplet (Gly-X-Y) 
are occupied by proline(Viguet-Carrin 2006). After the collagen 
polypeptide chains have been translated, proline and lysine amino acids 
become hydroxylated and subsequently the chains fold to form helices 
along most of their length(Lees 1977).  
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The presence of glycine at every third position along the alpha 
chains causes them to fold and form left-handed helixes along most of 
their length (there are non-repetitive, non-helical regions at each end). 
The three helical chains subsequently aggregate and intertwine to form 
a quaternary structure called tropocollagen (Figure 1.1)(Lees 1977). 
Tropocollagen molecules aggregate to form bundles called micro-fibrils 
(formed through covalent crosslinks between lysine residues) and then 
these aggregate further to form fibrils, which have typical diameters of 
50-200 nm and are the fibrous structural unit in the bone material(Smith 
1968; Lees 1977; Thurner 2009).  
 
The tropocollagen to collagen-fibril aggregation is an ordered 
process with the adjoining 300nm long tropocollagen molecules being 
offset from each other by 67nm along the long axis (Figure 1.2). Since 
the 300 nm is not divisible by 67 nm, a periodic banding pattern is 
created along the long axis where the ‘remainders’ line up, these holes 
are called gap regions and are thought to be where most of the mineral 
crystal nucleation occurs in the bone(Hulmes 1995). The neighboring 
tropocollagen molecules are joined together by covalent cross-links 
Figure 1.1: Structure of tropocollagen; three helical polypeptide chains aggregate and 
intertwine to form a quaternary structure. (adapted from http://www.sciencedaily.com)  
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found within and between the micro-fibrils. They are formed when one 
lysine residue in a tropocollagen’s helical region joins with a lysine 
residue from the non-helical (non-repetitive) region of another 
tropocollagen(Knott 1998). These crosslinks are of vital importance 
because when their function is inhibited using drugs, the bone material 
loses most of its strength (Bailey 1999). 
 
 
 The tensile strength of the collagen framework is provided by the 
intermolecular crosslinking of the collagen molecules making up the 
fibres of the framework. Despite its role as the fundamental framework 
of bone few attempts have been made to include the nature of the 
collagen crosslinks in the prediction of the mechanical properties of 
Figure 1.2: Tropocollagen to collagen-fibril aggregation is an ordered process. 
(adapted from http://www.sciencedaily.com) 
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bone. Stability of the collagen may vary depending on the nature and 
extent of the collagen crosslinks. Even a partial reduction in the extent 
of crosslinking produces a significant loss of mechanical strength in the 
bone.(Lees 1990; Oxlund 1995; Knott 1998) 
Initial attempts to correlate mechanical strength and intermolecular 
crosslinking revealed a surprising relationship between the tensile 
strength and the pyrole cross-link rather than the pyridinoline cross-link. 
These studies were carried out on avian tibiotarsus bone employing 
three-point bending to determine the tensile strength(Knott 1998). A 
more detailed study of the mechanical properties of human vertebral 
cancellous bone and the nature of the intermolecular cross-linking of the 
collagen demonstrated that the hydroxylysyl-pyridinoline/lysyl-
pyridinoline ratio appeared to be a significant predictor of strength (p = 
0.001) and stiffness (p = 0.001), samples with a high ratio being 
stronger and stiffer(Banse 2002; Banse 2002). The ultimate strain 
correlated with the hydroxylysyl-pyridinoline or lysyl-pyridinoline 
concentration.  
Further studies on the vertebral cancellous bone compared the 
nature of the collagen with the structural organisation of the trabecular 
network. Subjects with high pyrole and low pyridinoline in their bone 
collagen had a thicker and simpler structure, whereas those with a low 
pyrole and a high pyridinoline content possessed thin trabeculae that 
were more numerous(Banse 2002). This indicates a relationship 
between the structure and the stability of the collagen fibre controlling 
the micro-architecture of the bone.  
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1.1.2 Mineral Inorganic Phase 
The collagen fibrils are surrounded by a solid matrix of closely 
packed mineral crystals. These crystals are shaped like small plates, 
with thickness in the range of 2 to 7 nm, a length of 15-200nm and a 
width of 10-80nm. The mineral is analogous to naturally occurring 
hydroxyapatite, (Ca10(PO4)6(OH)2) but substitutions occur frequently 
with cations such as Mg2+, Sr2+, Fe2+, Pb2+, Na+, K+ take the place of 
calcium and anions such as CO32-, HPO42-, H2PO4-take the place of 
phosphate groups or hydroxyl groups(Boskey 2001; Fratzl 2004). 
 
1.1.3 Water and Non-Collagenous Proteins 
Water accounts for 5-20% of the weight of bone material(Lees 
1987). It fills pores where it acts as an interstitial fluid, diffusing nutrients, 
removing waste etc(Wilson 2006). It affects the mechanical properties of 
bone with dry bone being more brittle than wet bone even when the 
ration of organic material to mineral remains constant(Sedlin 1966; 
Fratzl 1993; Cowin 1999). 
A number of non-collagenous proteins (NCPs) have been shown to 
be important in controlling the mechanical properties of bone(Viguet-
Carrin 2006). Fibronectin, one of the most abundant NCPs, is thought to 
have a critical role in bone development and function; in particular it may 
regulate the mineralisation of bone by binding to other matrix proteins 
and also regulate osteoblast function. Another NCP, osteonectin, has a 
strong affinity for both collagen and mineral, may have an important role 
in mineralisation(Young 2003). 
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1.2 Bone at Higher Levels of Organisation 
 
1.2.1 Bone Microscopic Structure 
The mineralised collagen fibrils, which constitute the basic unit of 
bone matrix, can be arranged in many different ways to create bony 
materials that differ at the micro-scale and are better suited to specific 
functions. Many types of microstructure have been proposed(Weiner 
1992; Wagermaier 2006). However, in broad terms the microstructure of 
bone can be classified into two types, with time being the main 
determinant. In circumstances where bone needs to be created very 
quickly e.g. at fracture sites, osteoblasts lay down collagen fibres 
without regard to its structural order. This woven bone is inefficient, 
being highly mineralised yet having poor mechanical properties(Ritchie 
2009). At the other extreme is lamellar bone in which the mineralised 
collagen fibrils line up in one direction to form an ordered sheet (2-6µm 
thick) of bone. As alternate sheets (lamellae) are laid down the long 
axes of fibrils are tilted so that the material takes a plywood-like 
arrangement. Lamellar bone takes longer to form but is superior 
mechanically(Weiner 1998; Webster 2001). 
 
1.2.2 Bone Macroscopic Structure 
At a macroscopic level, bone material can be seen to be arranged 
in one of two distinct architectural states; cortical bone (compact solid 
bone such as the one found along the shaft of long bones) or cancellous 
bone (network of struts and plates, called trabeculae, forming a porous 
structure on the mm scale)(Webster 2001). 
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The larger scale structures formed from cortical and cancellous 
bone i.e. the whole bone organs, do not have fixed shapes but can be 
modelled and sculpted into new forms when they grow or when they 
have to adapt to new loading patterns or heal after an injury 
(fracture)(Goodship 1979).  
Even when the shape of the whole bone as a structure is static, the 
bone as a material itself can be turning over (constantly being removed 
and reformed), this process is called remodelling. The remodelling cycle 
begins when osteocytes (cells) living in lacunae (small cavities) in the 
bone material sense damage in their surrounding area, undergo 
apoptosis and release signalling molecules(Webster 2001).. These 
signalling molecules activate and summon large multi-nucleated cells 
called osteoclasts, which burrow into the bone surface by releasing H+ 
ions and dissolving the bone material. Next the resorption cavity is filled 
in with lamellar bone by specialised bone forming cells called 
osteoblasts (Figure 1.3).  
 
Figure 1.2: The Bone Remodelling Cycle. (adapted from www.coe-stemcell.keio.ac.jp) 
	   25	  
1.2.3 Mechanical Properties of Bone Material 
When bone material is subjected to a force it deforms. As the force 
increases, the deformation increases, until it reaches the point where 
the material breaks. For some forces, the removal of the applied force 
will allow it to go back to its original shape (i.e. will behave elastically) 
but for other larger forces, the material will remain deformed even after 
the force has been removed; the transition point between these two 
types of behaviour is known as the yield point(Turner 1993). Figure 1.4 
shows a diagram representing this behaviour.  
 
 
Figure 1.4: Stress/Strain curve. Stress (force/area), strain (elongated length-
original length/original length), tensile strength (maximum stress that a material 
can withstand while being stretched or pulled before failing or breaking), yield 
strength (maximum stress that a material can withstand without developing 
plastic deformation), fracture stress (stress upon which material fails) (adapted 
from www.keytometals.com). 
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The ‘stress’ and ‘strain’ labels refer to concepts from material 
science, which allow comparison between samples of different sizes and 
shapes. The area under the curve represents energy; the area under 
the whole curve gives the amount of energy the sample can withstand 
before breaking (toughness) and the area under the curve before the 
yield point, is the elastic energy. The Young’s modulus of elasticity is 
defined as the stress/strain ratio (N/m2; Pascals) in the elastic (pre-yield) 
region of the curve (cancellous bone: 0.5-1.5 GPa; cortical bone: 10-30 
GPa). 
 
1.3 Knee Joint Composition, Chemical Structure 
and Function 
The knee joint is a complex biological organ comprised of non-
mineralized cartilage, mineralized cartilage, bone, synovial fluid and a 
synovial membrane (also known as synovium). A schematic of knee 
joint anatomy is shown in Figure 1.5. Within the synovium, cartilage is 
attached to the joint surface of the patella, femur and tibia, and the 
cavity between and around the joint is filled with synovial fluid(Cohen 
1998). Synovium encapsulates the joint. Additional fibrous and ligament 
layers outside the synovium further contain the entire joint and help to 
stabilize the joint during motion. The knee joint is avascular and delivery 
of nutrients is controlled by diffusion through the synovium. Intricate 
biological, chemical and mechanical properties of cartilage, synovial 
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fluid and subchondral bone within the knee joint underscore its 
complexity in health and disease. 
 
Cartilage is a connective tissue located throughout the body and 
varies in physiological function, chemical composition and mechanical 
properties. There are three types of cartilage: hyaline, elastic and 
fibrocartilage. Hyaline cartilage is the focus of many studies because it 
is the type covering the ends of bones at the joints (as articular 
cartilage), and comprises epiphyseal plates where bones grow(Marieb 
1998). Articular cartilage provides a lubricated surface for joint 
movement and resists compressive forces. Chondrocytes, the cells 
which are responsible for the maintenance and repair of cartilage, are 
primarily found in the superficial layer near the articular surface and are 
surrounded by an extracellular matrix consisting of water, type II 
21 
 
  
 
Figure 1.1: Schematic of knee joint Figure 1.3: Schematic of Knee Joint [adapted from Netter’s Concise Orthopaedic 
Anatomy (Thompson 2010)] 
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collagen, proteoglycans, and glycoproteins, Water is a major component 
in cartilage, comprising between 60-80% of its total weight. 
The extracellular matrix of cartilage regulates nutrient diffusion, 
provides resistance to compressive forces, and adds tensile strength to 
cartilage. Type II collagen, glycoproteins, and proteoglycans intertwine 
to form the extracellular matrix. Articular cartilage is heterogeneous in 
the axial (vertical) direction in both the relative abundance of 
chondrocytes and type II collagen orientation. A cross-sectional view of 
articular cartilage is shown in Figure 1.6. The three zones of articular 
cartilage are defined primarily by type II collagen orientation. The 
superficial zone, located at the articular surface, contains the highest 
density of chondrocytes in cartilage tissue and type II collagen fibers are 
oriented parallel to the joint surface. In the tangential, or mid, zone 
collagen fibers are not preferentially oriented. Type II collagen is 
ubiquitous in the deep zone and is oriented perpendicular to the 
cartilage surface. Glycoproteins bound to type II collagen provide 
structural integrity and influence type II collagen fibrillogenesis(Kucharz 
1992). Proteoglycans consist of a hyaluronic acid backbone with core 
protein side chains. Sulfated glycosaminoglycans, chondroitin sulfate 
and keratin sulfate, are attached to the core protein. At physiological pH 
glycosaminoglycans are negatively charged and are highly hydrated. 
The unique viscoelastic properties of glycosaminoglycans, in addition to 
the high degree of hydration, renders to proteoglycans a sponge-like 
quality that provides compression resistance properties to cartilage. 
Aggrecan is the most abundant proteoglycan in cartilage. 
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Figure 1.6: Collagen Orientation and Chondrocyte Distribution in Articular 
Cartilage (Thompson 2010) 
 
Articular cartilage is unmineralized in the surface layers, but 
contains a layer of calcified tissue adjacent to subchondral bone. 
Calcified cartilage intertwines with subchondral bone to form a 
mineralized plate beneath cartilage and serves as the source of 
cartilage attachment to bone. Calcified cartilage provides additional 
structural integrity to the joint and limits diffusion across the 
bone/cartilage interface. The organic matrix of calcified cartilage is 
similar to non-mineralized cartilage and the mineral composition of the 
calcified layer closely resembles hydroxyapatite. The chemical 
composition of calcified cartilage resembles both cartilage and bone. 
Because the mineral in calcified cartilage is similar to the carbonated 
apatite in bone, it exhibits unique mechanical properties(Kim 1996; 
Ferguson 2003). In disease processes, like OA, it has been shown to 
hypermineralise and may therefore function as a hard, grinding 
abrasive, accelerating wear rates. The cortical bone that directly 
22 
 
 
  
 
Figure 1.2:  Collagen orientation and chondrocytes distribution in cartilage zones 
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underlies cartilage is called subchondral bone and it is composed 
primarily of type I collagen and a carbonated apatite mineral. 
Synovial fluid, a dialysate of plasma, fills the joint cavity space in 
diarthrodial joints and is essential to maintaining joint health and 
function. Synovial fluid is primarily composed of water, proteins, 
glycosaminoglycans, lipids, small inorganic salts, and metabolites such 
as amino acids or sugars. Synovial fluid functions include resistance to 
compression, nutrient diffusion, molecular signaling, and lubrication of 
cartilage surfaces(Fam ; Jay 2007).  
Synovial fluid molecules often have multiple functions and exhibit a 
large degree of interaction with other synovial fluid and cartilage 
molecules. For example, hyaluronic acid is responsible for the complex 
viscoelastic properties of synovial fluid but has also recently been found 
to regulate the biological activity of advanced glycation endproducts and 
cytokines and enzymes associated with late-stage 
osteoarthritis(Neumann 1999; Cowman 2005; Wang 2006)  
 
1.4 Osteoarthritis 
Arthritis is a disease or group of diseases/degenerative processes 
that are marked by the degradation of components in the synovial joint 
leading to an increase in fluid shear and hydrostatic pressure between 
two adjacent bones. The main form of arthritis, osteoarthritis (OA), is a 
degenerative joint disease with greater than 30% prevalence among 
individuals over 65 years(Guccione 1994; Gabriel 2001). The first and 
second decades of the new millennium have been designated Decades 
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of the Bone and Joint by the World Health Organisation and the United 
Nations, and the US National Institute of Health has set up the 
Osteoarthritis Initiative for the detailed study of human osteoarthritis. In 
2012, osteoarthritis is the disease with the fourth greatest impact upon 
the health of women and has the eighth greatest impact for men 
(Hochberg 2012). 
 Primary osteoarthritis occurs without an obvious cause or refers to 
the accumulation of mechanical damage that accompanies aging. 
Secondary OA occurs as a response to trauma, previous injury, obesity, 
or metabolic disease. The percentage of adults afflicted with OA 
increases with age, and results in an economic burden in lost wages 
and early retirement(Felson 2000). OA is one of the most common 
causes of disability in the elderly, and therefore has a high prevalence in 
an aging society(Guccione 1994).  
To date, there are no evidence based clinical treatments to reverse 
the cartilage damage characterized by osteoarthritis or to induce 
cartilage regeneration. Identification of osteoarthritis in its early stages is 
critical to disease management because minimally invasive therapies 
such as diet, exercise, non-steroidal anti-inflammatory drugs, or intra-
articular injections can be effective in delaying disease progression and 
ameliorating pain. However, by the time patients present with symptoms 
or once radiographic changes are evident, then OA is typically in an 
advanced stage. The challenge is to detect OA progression, especially 
for sub-clinical patients. There is a real need for new technologies able 
to detect and characterize OA at pre-symptomatic stages of disease and 
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to identify at risk individuals. 
The pathogenesis of OA is exceedingly complex, involving genetic 
and environmental factors as well as local biomechanical factors. OA 
was historically defined pathologically as focal and progressive loss of 
hyaline cartilage with concomitant changes in underlying bone. More 
recent studies have shown that osteoarthritis may be considered a 
whole joint disease and involve a range of constituent tissues and 
structures. Biological, chemical and viscoelastic changes affect 
cartilage, synovium, subchondral bone, synovial fluid, and surrounding 
muscles and ligaments(Radin 1986; Burr 1997; Oegema 1997; Felson 
2004; Dieppe 2005). Degradation of extracellular matrix molecules, such 
as cleavage of glycosaminoglycans or a loss of collagen cross-linking, is 
implicated in a complex series of biological, mechanical and chemical 
events that lead to loss of articular cartilage function. At the level of the 
articular chondrocyte, an altered composition of matrix, a pathological 
response to mechanical stress and programmed cell death contribute to 
the pathologic syndrome, with alterations in cartilage extracellular matrix 
proteins likely occurring early. 
The role of subchondral bone has been examined in current 
models of OA. A common consequence of osteoarthritis is thickening of 
the subchondral bone plate and increased apparent bone mineral 
density but significantly reduced material density associated with an 
altered composition of the bone in which the mass fraction of mineral is 
12% less than normal (Li 1997; Li 1999; Day 2004). Radiography and 
other imaging studies have shown alterations in bone architecture and 
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chemistry in addition to plate thickening(Matsui 1997; Bruyere 2003; 
Hunter 2003; Lahm 2004). Material properties in subchondral bone are 
also compromised, as observed by a less mineralized tissue and altered 
architecture in the cancellous and cortical bone regions(Bailey 2004). 
These studies support the idea that osteoarthritis is a disease that 
affects the entire joint.  
Clinical symptoms, such as pain, swelling or loss of function, are 
observed in most patients with osteoarthritis. However, these symptoms 
vary across patient populations, do not adequately correlate with 
disease stage and are non-specific to osteoarthritis. In 2004, Webb and 
colleagues reported the results of a population-based cross-sectional 
survey of knee pain(Webb 2004). The survey population included 
approximately 4,500 people living in the urban area of Manchester, 
England, divided into eight groups defined by age and gender. 
Symptomatically, OA is defined as pain with joint use; however, the 
cause of joint pain in OA has yet to be elucidated. 
Several bone changes occur in osteoarthritis, with osteophyte 
formation and, more importantly, subchondral plate sclerosis. Radin 
postulated that increased bone mass and thickening of the subchondral 
bone plate would cause stiffening of the bone and, as a consequence, 
cartilage destruction on repeated loading(Radin 1986). The initiation of 
cartilage destruction would be secondary to steep stiffness gradients in 
the subchondral bone. The most likely cause of such stiffness variations, 
according to the authors, is failure of the musculoskeletal peak dynamic 
force attenuation mechanisms. More recently, studies have re-
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emphasized the importance of bone changes. In patients with 
osteoarthritis of the knee and hand, Buckland-Wright reported thickening 
of the subchondral bone(Buckland-Wright 2004), while Carlson et al., 
using histological techniques, detected increased bone thickening with 
osteoarthritis progression in the cyanomolgus macaque model(Carlson 
1996). Both techniques revealed a marked increase in bone formation 
before cartilage fibrillation. Using labelled bisphosphonate in a 
scintigraphic study, Dieppe et al. demonstrated elevated bone turnover 
in those human patients that progressed to severe osteoarthritis(Dieppe 
1993; Dieppe 2005), while Mansell demonstrated increased turnover of 
the subchondral bone collagen(Mansell 1998) by measuring the 
carboxy-terminal propeptide content and alkaline phosphatase activity. 
The occurrence of these bone changes is not disputed, but, their 
importance in the pathogenesis of osteoarthritis remains contentious, 
and the mechanisms involved in these changes have received scant 
attention. There is now emerging evidence to suggest that changes in 
bone precede changes in cartilage, so that bone rather than cartilage 
may be the site of the causally most significant pathophysiological 
events(Mansell 2007). New treatments, focused on the cartilaginous 
component of the joint, such as injections to lubricate the joint or 
cartilage implants may therefore be at best short-term palliative 
measures. 
Resolution of the question of the importance of bone in 
osteoarthritis requires a multidisciplinary approach, including the 
disciplines of biomechanics, imaging, collagen biochemistry and cell 
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biology, as well as the development of animal models and the use of 
tissues from natural disease. 
 
1.5 Bone Structure and Metabolism in 
Osteoarthritis 
 
1.5.1 Collagen structure 
Simplistically, bone can be considered as a two-phase system of a 
collagenous supporting framework that provides strength and calcium 
apatite that confers rigidity, both phases being replaced during 
remodelling. Biochemical studies have revealed a several-fold increase 
in metabolism of the subchondral bone collagen in osteoarthritis, along 
with decreased mineralization in human femoral heads. 
Bailey et al have reported changes in the composition of collagen, 
with the type I collagen α1 homotrimer identified in osteoarthritic 
subchondral bone, indicating a changed phenotypic expression in the 
osteoblasts(Bailey 2002). Studies of transgenic mice with deleted α2 
chain have shown that such changes cause loose packing of the 
collagen chains and could therefore have a deleterious effect on the 
mechanical properties and mineralization of bone(Chipman 1993). 
However, the authors did not comment on whether these transgenic 
animals exhibited any clinical features of OA. 
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1.5.2 Cellular activity 
Many growth factors, which act to promote cell differentiation and 
activity, are stored in bone matrix, suggesting that these may be 
important in the coupling of the resorptive and formation processes of 
bone. Transforming growth factor β is related to bone 
turnover(Pfeilschifter 1998) and has been shown to be increased 
several-fold in osteoarthritic subchondral bone(Mansell 1998). Growth 
factors may also act as potential mediators of communication between 
bone and adjacent cartilage cells: for example, cells derived from 
osteoarthritic joints promoted the degradation of non-arthritic cartilage 
biopsies in vitro, whereas cells from normal joints did not do 
so(Westacott 1997). 
The turnover of the collagenous network in bone involves 
collagenases of the matrix metalloproteinase (MMP) family (MMP-1, 
MMP-8 and MMP-13)(Shingleton 1996); this suggests therapeutic 
targets to block production of these enzymes(Cawston 1996). However, 
the cathepsins, particularly cathepsin K, are also involved in the 
degradation of bone collagen(Garnero 1998), and the relative 
importance of the cathepsins and the MMPs remains to be determined. 
It has been proposed in the literature, that chronic hypoxia and 
anoxia, resulting in the generation of free radicals, initiate bone erosion, 
and that they should be considered a target for therapeutic manipulation 
in osteoarthritis(Jones 1987; Miller 1998). Hypoxia induces the 
production of xanthine oxidoreductase, which generates superoxide and 
nitric oxide, which leads to bone resorption. 
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1.5.3 Biomechanics of bone in osteoarthritis 
The results of studies of the mechanical properties of bone in 
osteoarthritis are conflicting. Bone taken from patients with osteoarthritis 
varies both in its properties and according to location. The subchondral 
bone from such patients is less stiff and dense (material vs. apparent 
density), shows greater porosity, has a reduced mineral content(Li 1997) 
yet is thicker than normal bone. These results complement the findings 
of biochemical studies(Mansell 1998; Bailey 2002), but are contrary to 
those of earlier studies, which suggested that subchondral bone was 
stiffer(Radin 1986). 
Bone is a dynamic mechanically sensitive tissue adapting to 
prevailing loading conditions. Disuse results in bone loss, allowing the 
skeleton to achieve sufficient strength without excessive mass, which 
would be energetically costly to build, maintain or use(Lanyon 1996; 
Skerry 1997). There is emerging evidence that different cell types in 
bone communicate though effector molecules and receptors that are 
similar to those that operate at synapses in the central nervous system. 
Studies, based on a differential display of osteocyte RNA following bone 
loading, have shown regulation of a glutamate transporter previously 
thought to be expressed only in the central nervous system(Mason 
1997). Such an arrangement would allow response to rapidly changing 
transient strains. Manipulation of such signaling pathways could provide 
a way of controlling bone mass in disease. 
In a different approach, bone cells cultured in vitro can be 
subjected to physiological levels of mechanical strain with resulting 
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changes to proliferative response and prostaglandin production(Murray 
1990). Suggestive differences between cells from osteoarthritic and 
normal patients have been observed, for example, in proliferative 
responses and prostaglandin production(Fermor 1998). The mechanical 
effects on osteoprogenitor and osteogenic cells warrant further 
investigation.  
Grynpas et al. measured the mineral content in bone through 
density fractionation, and found the OA subchondral bone (both the 
cortical plate and the underlying cancellous bone) to contain less 
mineral content than age-matched controls(Grynpas 1993). Therefore, 
from a material perspective, and contrary to intuition, bone mineral 
density actually decreases in OA. Burr suggests subchondral bone is 
constantly remodelling with a high turnover rate, preventing the matrix 
from fully mineralising. Consequently, subchondral bone has a lower 
material density in OA so the total volume, which is related to the 
apparent density, must increase significantly to provide a sufficient 
degree of structural stiffness. Therefore, the apparent density has to 
increase in OA, to compensate for the reduced material density, in order 
to provide an acceptable level of stiffness(Burr 2003). 
 
1.5.4 Animal models 
Bone changes occur in many non-human animal species (e.g. dog, 
horse), which also naturally develop osteoarthritis(Bailey 1997; 
Billingham 1998). These natural animal models allow the examination of 
the early stages of bone changes, as well as to test potential therapies. 
In macaques, where striking similarities to the slow human disease are 
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seen, Carlson et al. demonstrated histological evidence for thickening of 
the subchondral bone before cartilage fibrillation(Carlson 1996). Studies 
by Bailey and co-workers on spontaneous male Duncan Hartley guinea 
pigs suggest that bone density alterations accompanied by bone 
collagen remodelling are important in initiation and early disease 
progression(Quasnichka 2000). 
The hypothesis that bone sclerosis results from a change in joint 
mechanics, which in turn could be due to metabolic changes in the 
cruciate ligament(Bailey 1997) is supported by evidence from mice and 
guinea pigs, where ligament remodelling is seen before cartilage 
fibrillation(Anderson-MacKenzie 1999; Quasnichka 2000). 
The different animal models, both natural and induced, suggest 
that bone changes precede cartilage damage. Further studies are 
required to confirm that changes in the ligaments and subsequent 
changes in subchondral bone are major initiating events in idiopathic 
osteoarthritis. 
The changed view of the pathogenesis of osteoarthritis from 
cartilage to the involvement of the whole synovial joint, and the 
recognition of early changes in the bone and ligaments, provide the 
potential for a new approach to the understanding and novel treatment 
targets for this prevalent, painful and debilitating disease. 
Changes in bone and collagen play an integral part in osteoarthritis 
of the joint. Much work has already been done to clarify the changes in 
articular cartilage, but a greater effort must now be directed towards 
research into bone to redress the balance in our understanding of the 
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role of osteoarthritic changes at the osteochondral junction within 
synovial joints. 
 
1.6 Role of Subchondral Bone in Osteoarthritis   
The majority of the basic research into the pathogenesis of OA has 
concentrated on the mechanisms involved in the characteristic focal 
destruction of the articular cartilage. The initiating events of this 
destruction are believed to be changes in the proteoglycans followed by 
the collagenous framework, after which the disease is irreversible. 
The well-recognised additional characteristics of bony osteophytes 
and subchondral bone thickening have to a large extent been 
considered secondary and unimportant in the pathogenesis of 
osteoarthritis: the potential involvement of bone has been overlooked. 
Over four decades ago Johnson postulated that subtle changes in bone 
remodelling might precipitate irregularities in the articular 
cartilage(Johnson 1962). Radin and Rose later proposed that sclerosis 
of the subchondral bone plate would cause stiffening of the bone and 
result in cartilage destruction(Radin 1986). Newer radiographic 
techniques(Buckland-Wright 1994) have demonstrated progressive 
thickening of the subchondral bone with joint narrowing and technetium-
labelled bisphosphonate demonstrated that the heightened bone activity 
of the knee was related to the progression to severe OA, as monitored 
radiographically by joint space narrowing(Dieppe 1993). 
The question then arises as to whether the bone thickening is a 
result of cartilage degradation, occurs at the same time, or precedes 
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cartilage degradation(Bailey 1997; Burr 1998; Senior 2000). If the latter, 
then the subchondral bone thickening is indeed important in the 
pathogenesis of OA, either as an initiating factor or, at the very least, 
important in the progression of OA. Thickening of the subchondral bone 
was shown to occur prior to cartilage destruction in elderly cynomolgus 
macaques and that the thickness of the subchondral bone was related 
to the onset of cartilage fibrillation(Carlson 1996). Similar findings have 
been shown during spontaneous OA in the guinea pig knee 
(Quasnichka 2006). In a mechanically induced model it was reported 
that sub-fracture impacts applied to the patellofemoral joint of rabbits 
resulted in subchondral bone thickening after 6 months whilst cartilage 
stiffness only decreased after 12 months(Newberry 1997). In an attempt 
to detect earlier changes ultrasonography was employed in a rodent 
inflammatory joint model and reported changes in both bone and 
cartilage before any histological evidence of cartilage damage(Saied 
1997). 
However, regardless of whether thickening of the subchondral 
bone occurs at a late stage or precedes cartilage destruction it is 
important to know the biochemical and mechanical characteristics of 
bone in osteoarthritis, as they may be important in its pathogenesis.  
In an analysis of osteoarthritic human femoral heads it was found 
that collagen was turning over at a rate several fold greater than non-OA 
bone(Mansell 1998). The elevated type I collagen synthesis was 
accurately corroborated by the increase in alkaline phosphatase activity. 
The relative contribution of cathepsin K and the MMPs were not 
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determined. Transforming growth factor-beta (TGF- β) levels were 
increased 4-fold. TGF-β plays a major role in remodelling and 
recruitment of osteoblast precursors, stimulating collagen synthesis, 
inhibiting MMPs and increasing TIMPs thus leading to a net gain in 
collagen deposition(Pfeilschifter 1998). In contrast studies have shown 
that the mineral content of the new bone is significantly reduced (30%) 
with increased presence of osteoid(Grynpas 1991; Reinmann 1997). 
Higher turnover rate would lead to a higher proportion of immature bone 
suggesting a reduced mechanical strength. Cancellous bone from OA 
femoral heads is significantly weaker than age-matched controls(Li 
1997). 
The increased metabolism of bone collagen may be a feature of 
other bones in OA subjects. Interestingly, increased bone density and 
increased levels of TGF-β have been reported in the iliac crest bone of 
OA subjects(Dequeker 1993) and this suggests that the increased bone 
density of OA subjects protects them against osteoporosis(Dequeker 
1993). Certainly spontaneous fracture of femoral heads tends not to 
occur in OA subjects. 
Of additional importance is the fact that the increased turnover is 
not a function of age. Mature non-OA subjects have been investigated 
over a wide age range and did not show any changes in rate of turnover 
or the nature of the stabilizing collagen cross-links(Bailey 1999). Any 
changes found with increasing age are, therefore, likely to be due to 
disease processes. 
The extremely rapid turnover of the collagen in OA subchondral 
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bone means that the environment of the osteoblasts is very different 
from normal bone, and the consequent change in cytokines and growth 
factors could lead to differences in their phenotypic expression. Indeed, 
osteoblasts isolated from the bone of OA subjects were found to be 
capable of degrading cartilage proteoglycans in contrast to osteoblasts 
from normal bone(Westacott 1997) and possessed an altered response 
to various cytokines and growth factors(Hilal 1998). Bailey investigated 
the phenotypic expression of the osteoblasts in situ and demonstrated 
the presence of collagen, type I homotrimer (α1)3, in OA femoral heads 
in addition to the normal type I heterotrimer (α1)2α2(Bailey 2002).The 
amount of the homotrimer, demonstrated by the ratio of the α1 to α2 
chains varied considerably from subject to subject, from 4 : 1 to 17 : 1 
compared with 2 : 1 for normal bone. The authors suggest that the 
amount of the excess α1 chain depends on the rate of turnover and 
hence the severity of the OA, but further studies are required on 
clinically classified samples to confirm this suggestion. Cyanogen 
bromide cleavage of the homotrimer derived from OA subchondral bone 
revealed an identical peptide profile to the α1 chain of the heterotrimer 
isolated from the type I collagen of non- OA bone. The presence of the 
homotrimer is therefore due to a loss of the regulation controlling the 
α1/α2 ratio to produce an excess of α1, rather than a genetically distinct 
type I collagen α1-chain(Bailey 2002). 
To determine the effect of increasing amounts of type I homotrimer 
on the mechanical properties of the OA subchondral bone researchers 
have studied the mouse model expressing a variant of osteogenesis 
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imperfecta (oim) in which the α2 chain had been deleted (Chipman 
1993). The mechanical strength of the bones of these animals is about 
half that of the wild type mouse with a significant decrease in collagen 
chain cross-linking. Quite why the loss of the α2 chain should have such 
an effect on the cross-linking is not immediately obvious but could be 
related to an increase in hydroxyproline content on replacement of the 
α2 chain by the α1 which contains a higher hydroxyproline content, with 
348 hydroxyprolines compared with 327 for the heterotrimer triple helix. 
The mechanism of stabilisation of the triple helix by hydroxyproline is 
still controversial. It may be form stabilising hydrogen-bonded water-
bridges as originally proposed by Ramachandran(Ramachandran 1973), 
a proposal currently supported by recent X-ray studies defining the 
location of the water molecules on the triple helix (Bella 1995). 
Alternatively other workers have proposed that the hydroxyproline 
stabilises the trans configuration of the prolyl peptide bond by the 
inductive effect of its hydroxyl group suggesting that water hydrogen 
bonding plays no role in the stabilisation of the triple helix (Holmgren 
1998).  
Bailey proposes that the decrease in cross-linking and hence in 
mechanical properties, is due to the increased water content of the fibre 
rather than a distortion of the molecular structure(Bailey 2004). 
According to his theory, an increasing proportion of the weaker type I 
homotrimer fibres in the subchondral bone of OA subjects would have a 
significant effect on decreasing its mechanical properties. 
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In summary, the ability of bone collagen to provide a strong 
framework and to fully mineralise depends on the very precise alignment 
of the type I collagen heterotrimer. However, in osteoarthritis the 
increased narrowing of the fibre diameters, the reduced level of the 
pyrrole cross-link, the decreased mineralization, together with the 
increasing proportion of the homotrimer, all contribute to a weakening of 
the mechanical properties of subchondral bone. 
 
1.7 Bone Imaging and Analysis 
Bone has been imaged and analysed using many different 
analytical techniques. These can be classified into four general 
categories: radiographic techniques, other clinical in vivo techniques, ex 
vivo techniques and spectroscopic techniques. 
 
1.7.1 Radiographic Techniques 
 
1.7.1.1 Projection Radiography 
X-ray radiation is the name given to electromagnetic radiation with 
wavelength in the range of 0.1-10nm. The simplest x-ray technique is 
projection radiography in which an X-ray source is placed at one side of 
the limb/bone and a detector is placed at the other. As the different 
tissues absorb the X-rays, an image (analogous to a shadow) is created 
at the detector. The limitation of projection radiography is the fact that it 
produces a 2D image of a three dimensional object.  
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1.7.1.2 Computed Tomography 
This limitation is overcome with X-ray computed tomography 
(CT)(Mahesh 2002). Early CT scanners had an X-ray source which was 
aligned so as to be incident on the part of the body to be imaged e.g. 
the chest and a detector used to measure the signal at the other side of 
the chest. The source and the detector were then moved along the axis 
parallel to the original measurement and another reading was taken. 
This was repeated until data for a full slice of the chest was collected. 
The source and the detector were then rotated through a small angle 
and the same slice of chest was imaged from a slightly offset angle. This 
was repeated until the equipment was rotated for 1800, resulting in a 
large number of cross-sectional attenuation paths, crossing at all angles. 
Mathematical manipulation of the data set enabled a model of the slice 
to be created. 
In modern CT scanners, in order to speed up the measurement, 
the x-ray source and the detector are constantly moving through a 
helical path around the patient while the patient is moving headfirst 
through the helix in an opposite direction.  
 
1.7.1.3 Peripheral Quantitative Computed Tomography (pQCT) 
pQCT instruments work in a similar way as the older type CT 
scanners but have smaller sample space between X-ray source and 
detector. They are designed to create images of thin cross-sections and 
can give quantitative values for the amount of bone mineral present. 
The images obtained can be divided into trabecular and cortical regions 
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and by averaging the density across different topographical regions, the 
density of the trabecular or cortical bone can be obtained. 
 
1.7.1.4 Dual-Energy X-ray Absorptiometry (DXA) 
Compared to CT this technique is simpler and involves a much 
smaller dose of radiation. An X-ray beam is sent through the bone to be 
examined and the attenuation is measured, a second x-ray beam with a 
different wavelength is sent along the same path and its attenuation is 
also measured. This allows the mass per unit of projected bone to be 
calculated. 
DXA is used for measuring bone density and is currently the gold 
standard for the diagnosis of osteoporosis(Blake 1997). However it is 
limited by its planar nature. The density values it produces are a 
measure of x-ray absorption along the path of travel of the x-ray; a thin 
portion of highly mineralized bone will stop as many photons as a thick 
portion of under-mineralised bone, yet these two portions will have 
significantly different mechanical properties. Moreover DXA 
measurements cannot be separated for trabecular and cortical 
bone(Heaney 2005). DXA measured bone mineral density accounts for 
60-70% of the variation in whole bone strength (Rizzoli 2003). 
Radiographic techniques are useful and widely used but have two 
main limitations: 
1. X-rays are harmful; high-energy photons can ionize molecules 
they collide with and can create free-radicals which can damage 
DNA and/or destroy cells. 
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2. They do not allow for visualization of the organic phase of bone 
material. This normally accounts for 30% of the weight of the 
bone and is an integral part of the composite related to strength. 
This could explain some of the variation in whole bone strength 
that is not accounted for by DXA(Rizzoli 2003). 
 
1.7.2 Alternative Techniques 
 
1.7.2.1 Ultrasound  
Ultrasound vibrations can be used a medical tool, the sound wave 
sent through the body part to be probed and the reflected or transmitted 
sound (echo) is collected and analysed. Quantitative ultrasound that 
looks at the percentage of the signal that was transmitted and at the 
time the vibration took to propagate has been used to study 
osteoporosis, osteogenesis imperfect and hyperparathyroidism(Gregg 
1997; Danese 2001). Ultrasound techniques primarily probe the mineral 
phase of bone. 
 
1.7.2.2 Magnetic Resonance Imaging 
Magnetic Resonance Imaging (MRI) uses the magnetic properties 
of protons in different environments to distinguish between different 
tissues(Hendrick 1994; Pooley 2005). It can be used to probe a variety 
of connective tissues (e.g. bone, tendon, ligament, cartilage etc.) and 
the images produced give information about structure, function and 
pathology of bone and joints. Recently smaller MRI scanners have been 
developed, which have stronger magnetic fields and can produce 
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detailed localized scans (Magnetic Resonance Microscopy (µMR). They 
have enabled researchers to form in vivo images of bone microstructure 
and discriminate individual trabeculae(Genant 1996). 
The principle of MRI can also be used for chemical analysis. If the 
behaviour of a certain nucleus in a certain biochemical is known upon 
application of a magnetic field then one can study that in vivo. Magnetic 
Resonance Spectroscopy has been used to investigate tumours of 
breast, prostate, cervix and bone(Kurhanewicz 1996; Kvistad 1999). 
Magnetic Resonance Imaging does not involve ionizing radiation, is 
however time consuming and expensive and contraindicated in patients 
with implanted metallic devices. 
 
1.7.2.3 Positron Emission Tomography  
Positron Emission Tomography (PET) is a medical imaging 
technique that can be used to create 3D images on internal organs and 
tissues(Votaw 1995). In PET a bio-compound is labelled with radioactive 
markers, injected into the patient and its distribution around the body is 
measured as a function of time. PET is a quantitative technique and 
data obtained complement other imaging modalities well especially in 
assessment of tumours and infections in bone(Miller 1996).  
 
1.7.3 Ex-Vivo Imaging Techniques 
 
1.7.3.1. Atomic Force Microscopy 
Atomic Force Microscopy (AFM) is a technique in which the tip of a 
tiny probe needle mounted on a spring arm (cantilever) interacts with the 
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surface of the sample(Thurner 2009). It can also be used to measure 
the mechanical properties of samples (nanoindentation)(Donnelly 2010). 
 
1.7.3.2 Electron Microscopy 
Electron Microscopy (EM) can also be used to image the 
constituents of bone material(Boivin 1990). EM uses a beam of 
electrons in place of photons to image the sample. The electrons can be 
passed through a thin section of material and collected on the 
transmitted side (Transmission Electron Microscopy) or the signal they 
produce when they interact with the sample surface can be collected 
(Scanning Electron Microscopy) 
 
1.8 Raman Spectroscopy 
 
1.8.1 Background 
The inelastic scattering of light from matter is called Raman 
scattering, after the Indian scientist Chandrasekhara Venkata Raman 
who first discovered it. Raman studied the scattering of filtered sunlight 
from various liquids during the 1920s at the Indian Association for the 
Cultivation of Science in Calcutta. The experiments culminated on the 
28th February 1928 when he passed monochromatic light from a quartz 
mercury lamp through bulbs containing a series of liquid samples. 
Raman reported the results of this experiment to the South Indian 
Science Association on the 16th March 1928 in a talk titled “A New 
Radiation”(Raman 1928).  He stated ‘…most liquids showed in the 
spectrum of the scattered light, a bright line in the blue-green region of 
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the spectrum, whose position was practically the same for chemically 
similar liquids such as pentane, hexane and octane. There was 
however, a recognizable difference in the position of the modified line 
when other liquids such as benzene were used…’ (Raman 1928; 
Krishnan 1981). He was awarded the Nobel Prize in physics for his 
discovery in 1930. 
 
1.8.2 Scattering 
When light is incident on a molecule it can scatter, the scattering 
can be elastic with no energy exchanged between the photon and the 
molecule (Rayleigh scattering) or an inelastic process with energy 
exchanged between the photon and the molecule (Raman scattering). 
These scattering processes consist of two steps: 
1. molecule and photon combine to excite the molecule to a higher 
energy virtual state which exists for a very short time 
2. the photon is then released and the molecule returns to a 
vibrational state (either the original or a different one) 
A Raman scattering event that creates a photon with less energy 
(longer wavelength) is called Stokes scattering and a Raman scattering 
event that creates a photon with more energy (shorter wavelength) is 
called anti-Stokes scattering(Carey 1982). 
In order for anti-stokes scattering to occur the molecule must be in 
an excited state before the scattering event. Unless the scattering 
material is very hot and therefore in an excited state, most molecules 
will occupy the vibrational ground state; hence in normal conditions anti-
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Stokes scattering events will be much less numerous than Stokes 
scattering events. 
A scattering event from a molecule in its ground state can lead to 
Rayleigh scattering or to Stokes scattering but the probability of each 
event is very different. Rayleigh scattering is 106-108 times more likely to 
occur; hence the number of inelastically scattered Raman photons is 
comparatively tiny and Raman signal is very weak(Smith 2005). 
 
1.8.3 Intensity of Scattered Radiation 
The factors, which are important in determining the intensity of the 
Raman radiation from a material with vibrational ground state and 
excited state, are the intensity of the incident radiation, the wavelength 
of the scattered radiation (1/wavelength4) and the properties of the 
molecular vibration in question. These properties include the geometry 
of the molecule and the values of the electric dipole moment for each 
quantum mechanical state (vibrational or electronic)(Long 2002). 
Any molecular vibrations, which affect the ability of a molecule to 
become polarized by an electromagnetic wave, will be a relatively strong 
Raman scatterer. Therefore: 
 Stretching vibrations should scatter more than deformation 
vibrations 
 Multiple bonds scatter more than single bonds 
 Symmetric molecules with many conjugated electrons scatter 
more 
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1.8.4 Raman Spectroscopy Instrument 
A Raman instrument consists of three main components (Figure 
1.7): 
1. A light source. The availability of bright monochromatic light 
sources was one of the factors preventing the widespread 
adoption of Raman spectroscopy for many decades. However, 
since the latter half of the 20th century, cheap, efficient laser light 
sources have been developed. Modern lasers (Light Amplification 
by Stimulated Emission of Radiation) can emit light as a single 
wavelength from the ultraviolet to the near infrared and beyond, 
can deliver high intensities and can maintain their performance 
for many thousands of hours. 
2. A wavelength discriminator (filter). Firstly, a Raman spectrometer 
must have a component for separating the Raman signal from the 
light that has been elastically scattered from the sample; the 
much weaker Raman signal would otherwise be obscured. 
Secondly, the instrument must also be able to separate the 
different wavelength Raman photons in order to record a 
spectrum. Traditionally instruments use holographic notch filters 
(nowadays edge filters), made by imprinting inference patterns in 
optical media with laser beams, to remove the elastically 
scattered laser light. The Raman signal is then separated into its 
constituent wavelengths using dispersive techniques or 
interferometry techniques. 
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3. A detector. The current detector of choice is the Charged 
Coupled Device (CCD). A CCD camera consists of a 
semiconductor chip, which builds up electrical charge when 
electrons are incident on it; the charge is then read off by 
electrodes and recorded on a computer. The chip can have 
millions of electrodes on it and are designed so as to be more 
sensitive in the optical region of interest. 
	  
Figure 1.7: A Raman microscope with schematic of the laser pathway(Kelly 
2010). The filter firstly removes elastically scattered light and then separates the 
light into its constituent wavelengths using dispersion grating 
 
1.8.5 The Raman Spectrum 
In a Raman spectrum the energy of the scattered photons 
(wavenumber shifts) is recorded on the x-axis and the intensity of the 
Raman signal is recorded on the y-axis (Figure 1.8). The energy of the 
x-axis is represented as a wavenumber shift from the laser 
wavenumber, rather than an absolute wavenumber, enabling 
comparison of spectra recorded with different instruments and with 
lasers of different wavelengths. The units are inverse centimetres (cm-1) 
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and enable comparison between spectra recorded with different 
excitation wavelengths. The spectrum in Figure 1.8 shows the Stokes 
shifted side of the laser line, the anti-Stokes spectrum is to be found on 
the opposite side of the vertical axis and is much less intense. The 
intensity of the light is measured in detector counts and is associated 
with the charge coupled device (CCD) chip in the detector. 
Each Raman spectrum has several bands and each band has a 
frequency signifying the energy at which a vibrational transition takes 
place in the scattering molecule. In Figure 1.8 the phosphate band at 
960cm-1 means that laser photons with energy X were inelastically 
scattered from the phosphate in a sample (in this case bone) and during 
this process the photons lost an amount of energy corresponding to 
wavenumber shift of 960cm-1. The other bands correspond to other 
molecular vibrations and therefore their shape, position and intensity are 
different for each scattering molecule allowing for Raman spectroscopy 
to give a unique chemical fingerprint of the substance being studied. 
	  
Figure 1.8: Example of Raman spectrum of bone with main peaks labelled (by 
P.D. Gikas). 
56 
 
 
 
 
  
 
Figure 3.1:  Raman spectrum of subchondral bone 
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1.8.6 Advantages of Raman Spectroscopy 
1. Water is a weak Raman scatterer and therefore does not 
interfere strongly with Raman spectra. This means it can be 
used in vivo. 
2. Laser beams are relatively easy to use in a wide range of 
experimental setups and hence a variety of samples can be 
analysed. 
3. Lasers can be focused to very small points and hence 
photons can be scattered from well-defined areas with high 
spatial resolution. 
4. Raman spectroscopy does not involve any ionizing radiation. 
5. No need for sample preparation 
6. It is a non-destructive/non-invasive technique 
7. Specialized Raman techniques can be used non-invasively to 
depths of several millimeters with biological tissues, i.e., 
SORS and iSORS. 
 
1.8.7 Disadvantages of Raman Spectroscopy 
1. As the number of photons scattered inelastically from a material 
is a minority the Raman signals are inherently weak, which 
means that conventional Raman spectroscopy cannot be used to 
measure trace quantities and can also be overwhelmed by other 
sources of light. 
2. Raman spectroscopy is not suitable for pure metallic samples. 
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3. The laser can sometimes increase the temperature of the sample 
to undesirable levels and can cause degradation. 
4. Raman spectroscopy cannot be used on samples exhibiting 
strong fluorescence in the spectral region of interest. If the photon 
and the molecule’s energy gap have matching energies then this 
interaction is much more favorable than Raman scattering. 
 
1.9 Use of Raman Spectroscopy to Study Bone 
As aforementioned, the bands in a Raman spectrum represent the 
intensity of a particular frequency of Raman scattered light. The bands 
are specific to the type and proportion of chemical bonds that are in the 
sample and thus form a unique chemical ‘fingerprint’ of the sample. In 
other words, by comparing the bands with reference values/pure 
samples you can potentially determine what a given sample consists of. 
Raman spectroscopy can therefore be used as a diagnostic tool. 
Raman spectroscopy of bone is a relatively young field, with the 
possibility of obtaining Raman spectra from intact calcified tissue first 
demonstrated by Walton et al. in 1970(Walton 1970). The idea of using 
Raman as a diagnostic tool for bone disorders is undoubtedly attractive. 
What sets Raman spectroscopy apart from x-ray techniques and other 
imaging modalities is: 
 its ability to probe both organic and inorganic phases of bone 
 its ability to probe any single bone at different points 
 its safety profile 
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1.9.1 Effect of Age and Exercise on Bone 
Raman studies have demonstrated increased crystallinity of the 
hydroxyapatite phase i.e. degree of order and size of the crystals (ν1 
phosphate band) with increasing age in mice(Freeman 2001; Akkus 
2004). Age-related changes of the organic phase of bone material have 
also been investigated using Raman and it has been shown that the 
amide I band increases in intensity with age, something that may reflect 
changes in cross-linking of collagen and correlate with decreased 
fracture toughness(Akkus 2003; Ager 2005). 
Raman spectroscopy has also been used to demonstrate that 
exercise causes compositional changes in tibial bone material, with 
mineralization (ν1 phosphate band to proline/hydroxyproline band) being 
significantly increased in exercised bones relative to controls(Kohn 
2009). 
 
1.9.2 Effect of Mechanical Loading on Bone Material 
The response of the chemical structure of bone to large 
mechanical stresses has been studied with Raman spectroscopy. In one 
study(Carmejane 2005) pressure was seen to induce large shifts in the 
position of collagen bands. The CH2 bands shifted towards higher 
wavenumbers (reversible) whilst the amide I band shifted towards lower 
wavenumbers (irreversible). All the mineral bands shifted reversibly. The 
authors suggested that the irreversible shifts in the amide I band are 
associated with changes in protein secondary structures such as cross-
linking and helix pitch. On the other hand, the reversibiliy of the mineral 
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Raman bands has been taken as evidence that it is very hard for water 
to move out of the crystal lattice. 
The response of bone to elastic deformation in the physiological 
range has also been examined using Raman, with the centre of gravity 
of phosphate bands shifting on tensional loading indicating that the bone 
mineral may not be a passive contributor to tissue strength but rather 
function as a local energy storage and dissipation mechanism, thus 
helping to protect tissue from catastrophic damage(Morris 2004). 
 
1.9.3 Effect of Radiation on Bone Material  
Raman Spectroscopy studies that look at the effect of ionizing 
radiation on bone material have shown that the organic phase suffers 
much more damage than the mineral phase(Kubisz 2007; Polomska 
2010). 
 
1.9.4 Raman Studies of Non-Collagenous Proteins in Bone 
In a study using knock-out mice for fibrillin 2 it was found that the 
femora of the mutant mice had lower hardness and lower elastic 
modulus than the wild type controls. Raman however failed to 
demonstrate any significant difference, suggesting that fibrillin 2 may 
have a unique role in determine the mechanical properties of bone 
material (e.g. needed to control collagen fibril 
arrangement)(Kavukcuoglu 2007). 
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1.9.5 Raman Studies of Bone Microstructure 
Raman spectroscopy has a theoretical spatial resolution of 1µm 
and can therefore probe collagen fibrils, which are aligned in specific 
directions. Studies have confirmed that the phosphate ν1 to amide I ratio 
is best for looking at the orientation of the lamellae whilst phosphate ν2 
to amide III and phosphate ν2 to carbonate are best for bone material 
composition(Kazanci 2007). The composition versus orientation 
methods were used to look at anatomically identical regions of femur in 
mice of different ages, the results suggesting that there is an evolution 
of both orientation and chemical composition as a function of tissue age 
within the same specimen(Gamsjaeger 2010). Hence Raman 
spectroscopy can be used not only to gain information about 
composition (e.g. mineral to collagen ratio) but also to study the 
organization of bone constituents. 
 
1.10 Use of Raman Spectroscopy to study Bone 
through Skin and Soft Tissue 
The Raman studies summarized so far have all used excised bone 
material that had laser light shone directly onto its surface. More 
recently techniques have been developed which allow Raman 
spectroscopy of bone through skin and overlying tissue therefore 
permitting the potential development in the future of Raman 
spectroscopy as a non-invasive diagnostic tool in day to day clinical 
practice. 
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1.10.1 Kerr Gate 
If a molecule that is in an excited electronic state relaxes back 
down to the electronic ground state and releases the energy as a 
photon, the process is called fluorescence. Skin, muscles and other soft 
tissues, unlike bone, consist of large biological molecules (small 
electronic energy gaps) and fluoresce strongly. The fluorescent photons 
along with the surface Raman signal will often saturate the detection 
equipment and drown out the Raman signal making transcutaneous 
analysis very difficult. The emitted fluorescence photons themselves can 
be collected and used as a spectroscopic signal however a fluorescence 
spectrum will have wide overlapping bands and hence much lower 
chemical specificity. The property that accounts for the differing 
chemical specificity between Raman and fluorescence is the timescale 
associated with each process. The Raman scattering event occurs so 
quickly that the photons capture ‘snapshots’ of the target molecule, 
whereas the longer timescales associated with the fluorescence process 
allow time for the excited electronic state to change energy due to 
thermal collisions with other molecules. Therefore, the gap between the 
excited and ground state varies during fluorescence and hence the 
emitted photon energy varies and hence the spectrum will have 
overlapping bands. 
The temporal difference between the Raman and fluorescence 
processes has been exploited using Kerr-gate technology to produce 
fluorescence-reduced spectra. The technology has developed to enable 
the retrieval of Raman spectra of bone through 1mm of skin and tissue 
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and the discrimination between healthy and pathological bone 
material(Morris 2004; Morris 2005; Morris 2005). Draper et al. used this 
technology to analyse metacarpal bones of mice from two distinct 
genotypes: wildtype and oim/oim(Draper 2005). The oim/oim mice were 
used as a model for osteogenesis imperfecta as they only produce 
homotrimeric collagen, which is associated with poor mineralisation. The 
measurements were repeated with the overlying tissues removed and 
therefore measured bone directly.  They found that the spectrum 
produced through skin contained more noise but essentially was the 
same as the spectrum produced through bone directly. They showed 
that the phosphate peak was less intense and the organic CH2 wag 
peak was more intense in oim/oim specimen than the wildtype 
specimen. The phosphate:CH2 band area ratio was higher in the 
wildtype specimen than the oim/oim specimen. All of the results 
obtained were therefore consistent with what was expected providing 
evidence that Raman spectroscopy could reliably detect the difference 
in bone quality in a non-invasive manner. 
However, the inherent instrument complexity limits is applicability 
and this led to the development of spatially offset Raman spectroscopy 
(SORS). 
 
1.10.2 Spatially Offset Raman Spectroscopy 
SORS relies on the fact than laser photons that enter through the 
surface of a medium will increasingly diffuse in lateral directions the 
further they travel through the medium. This means that photons 
returning from deep in the medium will be more likely to emerge far from 
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their entry point than photons which made only a short journey to the 
surface from more shallow regions. 
Shortly after the development of SORS, it was demonstrated that 
Raman spectra of bone material could be retrieved through skin and 
other overlying tissues using animal specimens and living human 
subjects (up to 4 mm of depth)(Matousek 2006; Schulmerich 2006; 
Schulmerich 2006). 
SORS also has excellent capability to dampen melanin-induced 
fluorescence from skin and this further enhances its use in vivo. 
Matousek et al. performed the first transcutaneous Raman spectroscopy 
of human bone in vivo using SORS to provide a safe laser 
level(Matousek 2006). A further development to SORS is inverse SORS 
(iSORS), which enables the use of higher laser powers through a wider 
laser-exposed surface. The difference between SORS and iSORS is 
essentially the area of laser focus and the area of collection of Raman 
scattering. In SORS the laser beam is focused centrally and the Raman 
scattering is collected peripherally whereas in iSORS the situation is the 
opposite so the laser beam is focused peripherally and the Raman 
scattering is collected centrally. 
 
1.11 Pre-processing 
Following spectral acquisition the spectra must be pre-processed 
to account and correct for sample thickness, sloping baseline effects 
and to select the spectral region of interest. This is a current area of 
research. 
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1.11.1 Cut and smoothing 
The region of interest in the study of biological specimens is 1800 
cm-1 – 900 cm-1, referred to as the biochemical-cell fingerprint. The 
spectral region usually selected in Raman spectroscopy is within 2000 
cm-1 – 350 cm-1.  
 
1.11.2 Baseline correction 
The raw data obtained from Raman spectroscopy need to be 
baseline corrected in order to account for fluorescence.  
 
1.11.3 Normalisation 
Normalisation is employed to scale the spectra and remove 
spectral changes accountable by the thickness of the sample.  
 
1.12 Multivariate Analysis 
 
1.12.1 Principal component analysis (PCA) 
PCA is an unsupervised multivariate technique used to analyze the 
inherent structure of the data. PCA reduces the dimensionality of the 
data set by finding an alternative set of coordinates: principal 
components (PCs). PCs are linear combinations of the original 
variables, which are orthogonal to each other and constructed in such a 
way that each one successively accounts for the maximum variability of 
the data set. The PCs may be plotted as pseudo-spectra called loadings 
curves. They are also used for the axes of scores plots, where each 
spectrum is represented by an individual point, or score (Figure 1.9). 
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Scores plots allow the identification of segregation in the data set as 
clusters. The closer together two scores are the more similar they are 
biochemically, and vice versa. The interpretation of the scores, followed 
by the loadings allow the reasons for any segregation to be 
identified(Jollife 1986; Brereton 2003).  
	  
Figure 1.9: Example of PCA scores (A) and loadings (B) (Kelly 2010). 
 
1.12.2 Linear discriminant analysis (LDA) 
LDA is a supervised multivariate technique, meaning that 
information regarding how many groups there are and which samples 
correspond to each group is taken into account during the analysis 
process. This method maximizes the ratio of between-class variance to 
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the within-class variance in any particular data set thereby guaranteeing 
maximal separability. 
The goals of LDA are somewhat similar to those of PCA. But 
different from LDA, PCA is an unsupervised technique and as such does 
not include label information of the data, effectively ignoring this often 
useful information. LDA explicitly attempts to model the difference 
between the classes of data. PCA on the other hand does not take into 
account any difference in class, and factor analysis builds the feature 
combinations based on differences rather than similarities. 
LDA can be used to produce a scores plot, where relative 
distances correspond to dis(similarities) in the data. Additionally, a 
loadings plot may be produced and interpreted to provide wavenumbers 
(and corresponding biochemical) responsible for segregation between 
classes(Kelly 2010). 
A downside of LDA is that it is a parametric method assuming 
unimodal Gaussian likelihoods. If the distributions are significantly non-
Gaussian, the LDA projections may not preserve complex structure in 
the data needed for classification(Brereton 2003). 
 
1.12.3 PCA-LDA 
LDA may be performed on the output of data from PCA. This 
allows data reduction, and therefore removal of noise from the dataset 
prior to supervised analysis. Loadings/cluster vector plots may be 
interpreted to identify reasons for spread within the data and any 
biomarkers distinct to classes (Figure 1.10). This is true for both PCA 
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and PCA-LDA, although the latter may be more precise in determining 
inter-classes distinctions(Kelly 2010). 
 
	  
Figure 1.10: Example of PCA-LDA scores (A) and loadings (B) (Kelly 2010). 	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CHAPTER 2 – AIMS  
 
2.0 General Aim 
The general aim is to investigate the quality of subchondral bone in 
human osteoarthritic tibial plateaus. Normal tibial plateaus are used as 
controls so comparisons can be made. The term ‘bone quality’ is vague 
and cannot be measured directly. Instead, several parameters are used 
as markers for bone quality: mineral to matrix ratio, carbonate to 
phosphate ratio, carbonate to amide I ratio, amide I to amide III ratio and 
volumetric bone mineral density. These parameters have been used 
previously in the literature to define bone quality and the former two 
ratios are the most validated markers for bone quality in spectroscopy 
studies(Morris 2011). The phosphate to amide I ratio (mineral to matrix) 
indicates the degree of mineralisation and the carbonate to phosphate 
ratio indicates the extent of carbonate accumulation in the apatite 
crystals. The carbonate to amide I ratio may indicate bone 
remodelling(Morris 2011). Finally in our work we have used the amide I 
to amide III ratio as an indicator of collagen differences between our 
cohorts. This has not been previously validated and although the results 
will be cautiously interpreted, any differences nevertheless can 
potentially suggest quantitative and or qualitative collagen changes 
between healthy and diseased tissue. 
The majority of the research done on subchondral bone has failed 
to accurately distinguish it from cancellous bone. In this study, 
subchondral bone is limited to within 3mm of articular cartilage. The 
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secondary aim is to investigate the presence of homotrimeric type I 
collagen in osteoarthritic bone using sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS PAGE). 
 
2.1 Hypotheses 
a) There is no difference in the vBMD and subchondral bone 
thickness in osteoarthritic tibial plateaus compared to controls. 
b) There is no difference in the phosphate to amide I ratio, 
carbonate to phosphate ratio, carbonate to amide I and amide I to amide 
III ratios in osteoarthritic tibial plateaus compared to controls. 
c) There is no difference in the levels of homotrimeric type I 
collagen in osteoarthritic and controls specimens. 
 
2.2 Objectives and Study Design 
a) To measure the subchondral bone density and subchondral bone 
thickness in OA and non-OA control specimens. 
b) To acquire Raman spectra from OA and non-OA control 
specimens and to subsequently perform univariate and multivariate 
analysis 
c) To quantify levels of homotrimeric alpha 1 collagen in bone form 
subchondral plate in OA and non-OA control specimens.  
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CHAPTER 3 – MATERIALS AND METHODS 
 
3.0 Ethical Approval 
Ethical approval was sought and granted from the Stanmore 
Biobank (09/H0304/78) for collection of human tissue at the Royal 
National Orthopaedic Hospital, Stanmore UK and transfer to the 
laboratories of the UCL Institute of Orthopaedics and Musculoskeletal 
Science at the Royal National Orthopaedic Hospital site (Stanmore, UK) 
for storage and analysis.  Ethical approval was also granted for the 
collection of cadaveric lower limbs from The Vesalius Clinical Training 
Centre at the University of Bristol – www.bristol.ac.uk/vesalius  
(08/H0724/34), from people who had previously consented to donate 
their bodies for medical research. 
 
3.1 Specimen Collection and Storage 
Five cadaveric tibiae were obtained from the The Vesalius Clinical 
Training Centre at the University of Bristol, UK.  There was no clinical 
and radiological history of osteoarthritis or metabolic bone disease in 
any of the donors. The tibial plateau was excised en bloc using a AEW 
Thurne 350 band saw (AEW Delford Systems, Norwich, UK) at a blade 
speed of 27m/s. All five cadaveric specimens were examined and 
confirmed not to have any macroscopic features of osteoarthritis (intact 
articular cartilage with absence of softening, fibrillation and fissuring; 
Grade O Outerbridge Classification, see Figure 3.1).  
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Figure 3.1: Outerbridge classification: Grade O = normal cartilage; Grade I = 
softening (A); Grade II = fissuring but < 50% (B); Grade = III fissuring and > 50% 
(C); Grade IV = full-thickness lesion (D) (adapted from www.healio.com). 	  
Five normal tibial plateaus were retrieved following surgery at the 
Royal National Orthopaedic Hospital from patients undergoing 
oncological operations involving massive en bloc excision of the knee 
joint. There were no clinical or radiological signs of osteoarthritis and the 
primary disease process did not affect the tibias (distal femoral 
pathology). Weight bearing was not affected as a result of the primary 
disease process. 
Ten tibial plateaus were retrieved at surgery from the Royal 
National Orthopaedic Hospital from patients undergoing primary total 
knee replacement for clinically and radiologically diagnosed 
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predominantly medial compartment osteoarthritis.  Patients with post-
traumatic osteoarthritis were excluded from the study.   
All patients gave informed written consent to allow retention and 
analysis of their tibial plateaus for the purpose of the study.  The 
samples were removed in the standard manner during the operation, 
briefly stored in a fridge before transportation to our laboratory the same 
day.   All soft tissue was excised from around the specimens and they 
were stored in a Sanyo VIP series ultra low temp freezer (Sanyo 
Biomedical, Japan) at a temperature between -70 and -80°c. 
 
3.2 Densitometry pQCT Measurements 
Peripheral quantitative computerized tomography (pQCT) is a 
method of accessing bone mineral density, which uses multiple cross-
sectional x-rays to reconstruct a volumetric model of the bone density 
distribution. The analyzed bone mineral density is presented as mg/cm3. 
Other densitometric technologies, using isotopes, x-rays, or 
ultrasound, yield results based upon a weighted average of combined 
trabecular and cortical bone. These older technologies employ a 2-D 
projection of the bone which super-imposes trabecular and cortical 
bone. They are, therefore, unable to isolate specific bone components. 
Advantages of pQCT include: 
1.  Measurements of volumetric bone mineral density (vBMD, in 
mg/cm³), as opposed to DEXA scanning, which provides area 
bone mineral density (aBMD, in mg/cm²). Use of aBMD to assess 
samples does not take into account the third dimension and 
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therefore may lead to erroneous conclusions due to differences in 
bone size (Bennel et al.,2008). 
2. The ability to analyse cortical bone and trabecular bone 
separately (Bennel et al.,2008). This is particularly relevant when 
scanning subchondral bone as the subchondral cortical bone and 
underlying trabecular bone can be distinguished. 
3. Utilises thin cross-sectional slices, this is particularly important for 
studying the effects of OA, as variations in load across an 
articulating surface, such as the proximal tibial plateau, will 
probably result in heterogeneous subchondral densities (Bennel 
et al.,2008).   
 
3.2.1 Validation of pQCT Apparatus 
 
3.2.1.1 Quality Assurance 
The quality assurance (QA) measurement is used to check all 
components of the pQCT apparatus. It is performed every working day 
to detect any possible defects. It is not a calibration of the system as the 
scanner is so stable that no drift is visible for several years. 
QA measurement was performed by fixing the QA phantom in the 
phantom holder and placing it in the fixation for the measurement tube. 
The position of the CT scan and subsequent measurements are 
performed automatically by the system software. The software 
compares the measured values with the rated values and gives the 
message “QA successful” if the difference between measured and rated 
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values is smaller than 1%. QA measurements were always successful 
during the course of this work. 
 
3.2.1.2 Repeatability 
In order to confirm that the pQCT apparatus gave the same 
response to the same experimental conditions, repeated vBMD of a 
sample were recorded. A piece of diaphyseal cadaveric human femur 
sectioned along the coronal plane was used and cortical vBMD was 
calculated at 2 cm intervals along its length. Without changing anything 
another set of measurement was recorded. Five measurements were 
recorded five times in this way.  
 
3.2.1.3 Reproducibility 
Reproducibility was also investigated. A piece of diaphyseal 
cadaveric human femur sectioned along the coronal plane was placed 
on the sample stage and vBMD was measured at a location 5 cm from 
its proximal end (position marked). The sample was then removed, and 
subsequently placed back on the stage, so that the measurement was 
repeated on the same area 5 times.  
 
3.2.2 pQCT Measurements 
Samples were allowed to defrost at room temperature for a 
maximum of 2 hours. QA measurement of the pQCT XCT 3000 (Stratec, 
Pforzheim, Germany) scanner (Figure 3.2) was performed with a 
phantom.  
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  XCT 3000 Stratec (version 6.00) software was loaded and details 
of the specimens entered.  The samples were placed horizontally in a 
Stratec XCT 3000 pQCT scanner, ensuring same orientation and 
supported on a ruler base with low x-ray attenuation. Specimens were 
scanned in two mm increments; considered a small enough distance to 
gather data from specific sites. The images gathered allow the 
distinction between cartilage, subchondral cortical bone and 
subchondral trabecular bone. The x-ray beam width was 2mm and the 
voxel size was fixed at 0.3mm.  The threshold for trabecular and cortical 
human bone was defined according to the manufacturer’s specification 
as 280 and 710mg/cm3 respectively. A measurement slice from the 
centre of each compartment of the plateau (red dashed line indicated in 
Figures 3.3A and 3.3C) was used to calculate the vBMD (mg/cm3) of 
the subchondral bone; the regions of interest (ROI) used for this were 
the same size and location across all measurements (Figure 3.4). 
Additionally, on the same slice, the thickness of the subchondral bone 
was also measured in mm, by drawing a line on the ROI image from 
Figure 3.2: The pQCT XCT 3000 scanner 
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proximal to distal. The regions of interest (Figure 3.4) were used to 
calculate volumetric bone mineral density to an accuracy of ±5.0mg/cm3. 
 
 
 
 
 
Figure 3.3: Tibial plateau post-operative photos and pre-operative radiographs [A] OA photo; 
[B] OA radiograph; [C] Photo of non-OA; [D] Radiograph of a non-OA knee. Red dashed lines 
indicate the plane the pQCT measurements were taken. 
 
Figure 3.4: PQCT scan of the lateral side of a tibial plateau (left), showing cartilage (grey) 
overlying subchondral cortical bone, and the medial side of a tibial plateau (right), showing 
cartilage wear (thin, almost absent grey layer) and dense subchondral cortical bone exposed. 
Small yellow squares (arrows) demarcate region of interest (ROI) wherefrom density 
measurement is recorded. 
lateral medial 
1 cm scale 
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3.3 Collagen Biochemistry to Determine Alpha 
Chain Ratios 	  
3.3.1 Validation of Biochemistry Technique 
A collagen and molecular weight standard was used in all gels 
giving reproducible results with an alpha chain ratio of two alpha 1:one 
alpha 2 chains equal to 2.476:1. 
 
3.3.2 Tissue Preparation 
Cores from specific sample regions were taken using a circular 
2mm punch (Jamshidi needle). The cores were obtained from the centre 
of the medial and lateral plateaus. The cores were then defatted with 
5ml of pure acetone and left for an hour at 37°C. This step was repeated 
twice more. The acetone was then washed off the cores with deionised 
water and dried. They were then weighed prior to decalcification. 
Decalcification involved immersing the cores in 10ml of 10% EDTA at a 
pH of 7.5. This was left to stir for 10 days at 4°C. The insoluble 
collagenous residues were then centrifuged at 4600 rpm for 10 minutes 
at 20°C. The cores were washed with deionised water (to remove 
excess EDTA) and freeze-dried. The cores were then re-weighed and 
the weight loss assessed. Five milligrams from each selected sample 
was isolated for further processing. The selected decalcified 
collagenous cores were each immersed in 1ml of 0.5M acetic acid with 
25µg of pepsin added (0.5% w/w of 5mg cores). They were left to stir for 
2 days at 4°C. The cores were then centrifuged at 13000 rpm for 15 
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minutes at 4°C. The supernatants were harvested and freeze-dried 
overnight. 
 
3.3.3 Sodium Dodecyl Sulphate PolyAcrylamide Gel 
Electrophoresis 
Samples prepared as above, were dissolved in 0.5ml of sample 
buffer and then heated in a water bath at 60°C for 10 minutes. The Mini-
Protean II apparatus (Bio-Rad, Hemel Hempstead, UK) was assembled 
according to the manufacturer’s instructions. The 7.5% polyacrylamide 
resolving gel matrix was prepared and immediately poured between the 
two glass plates and overlaid with a layer of deionised water. The gels 
were left to set for 30 minutes. The layer of water was discarded and 
filter paper used to dry the plates. The 4.5% stacking gel was then 
prepared and immediately poured between the two glass plates. Combs 
were inserted and positioned into the gels. The gels were left to set for 
30 minutes and the running buffer prepared. Once the gels solidified, 
the combs were removed and running buffer added to the wells. The gel 
plates were clipped into the frame to make the upper reservoir and 10µl 
of each sample was loaded into the wells using specialised pipette tips. 
The upper reservoir was positioned into a tank and running buffer added 
to fill the upper reservoir and the majority of the tank. The lid was closed 
and the red and black leads plugged into their respective locations in the 
power pack. The gels were run at a constant current of 40mA 
(20mA/gel) and a starting voltage of 162V as per protocol. They were 
run until the dye front reached the end of the gel. After electrophoresis, 
the gels were stained overnight with Coomassie Blue and then 
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destained with 10% acetic acid and 20% methanol solution. The gels 
were photographed and the images analysed using Image J (version 
1.45) software. This program was used to quantify the band intensities 
of type I collagen α1 and α2-chains. The α1: α2-chains ratio was 
subsequently calculated for each sample. 
 
3.4 Raman Spectroscopy 
 
3.4.1 Validation of Raman Apparatus 
 
3.4.1.1 Calibration 
The Raman instrument is calibrated prior to use with silicon and 
polystyrene. The former has the centroid of the peak at 520.5 cm-1 and 
the latter at 1001 cm-1 and 1031 cm-1. The instrument is adjusted 
following silicon calibration until the peak obtained corresponds to the 
one expected. The polystyrene test is an additional check to confirm the 
calibration done with silicon and to ensure that it is accurate.   
 
3.4.1.2 Repeatability 
In order to confirm that the instrumentation gave the same 
response to the same experimental conditions, repeated spectra of a 
sample were recorded. A piece of bone from the midshaft of a human 
cadaveric femur was used and a spectrum was recorded. Without 
changing anything another spectrum was recorded. Ten spectra were 
recorded in this way.  
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3.4.1.3 Reproducibility 
Reproducibility was also investigated. A piece of cadaveric human 
femur was placed on the sample stage and a spectrum was recorded. 
The sample was then removed, and subsequently placed back on the 
stage, so that the laser illuminated roughly the same area, and another 
spectrum was recorded. Ten spectra were obtained this way.  
 
3.4.2 Raman Measurements 
Cores from central portions of the medial and lateral parts were 
taken from each tibial plateau slice using a circular 2 mm punch 
(Jamshidi needle). A single core was taken from each area of interest 
and each one incorporated at least 3mm of subchondral bone. Cores 
were then defatted with 5ml of pure acetone and left for an hour at 37°C. 
This step was repeated twice more. The acetone was then washed off 
the cores with deionised water and dried and frozen for later use. All 
specimens were defrosted for a minimum of 60 minutes prior to Raman 
spectral analysis.  The subchondral bone was analysed with the 
Renishaw inVia Raman microspectroscopy (Gloucestershire, UK), a 
class 3B laser with 300mW power and 830nm wavelength (Figure 3.5). 
A Leica 50x long working distance (LWD) microscope objective was 
used to focus the laser, ensuring accuracy and precision of the 
readings. The position of the microscope objective with respect to the 
bone tissue was manually controlled in the three axes during surface 
mapping. Ten independent Raman spectra were acquired from each 
sample allowing us to obtain average value of compositional and 
structural parameters of each tibial plateau core. The samples were 
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measured in room temperature. Cosmic ray artifacts were removed 
during acquisition and band spectral parameters were obtained by 
deconvolution in the WIRE 3.1 (Renishaw) software. 	  
 
 
3.4.3 Pre-processing 
The data collected was pre-processed using INT13.exe, MATLAB 
(version 2007b) software. The raw data was baseline corrected to 
account for fluorescence. This was done in two steps. First the raw data 
was baseline corrected for wavenumbers in the range 350 – 1150cm-1 
using a polynomial power of 3. The process was then repeated for 
wavenumbers in the range of 1150 – 1800cm-1. The baseline corrected 
data were then normalised using Microsoft Office Excel 2007. This 
involved subtracting the lowest intensity (which was at the 1800cm-1 
wavenumber) from the data and then dividing the resultant data by the 
highest intensity (which was at the 960cm-1 wavenumber) thus 
normalising all spectra to the v1 phosphate peak. The peaks of interest 
Figure 3.5: The Renishaw inVia Raman microspectroscopy apparatus. 
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are labelled in Figure 3.6 and include the v1 phosphate peak (961cm-1), 
v1 carbonate B-type peak (1070cm-1), amide I (1658cm-1) and amide III 
(1247cm-1) peak (Penel 2005; Kazanci 2007; Morris 2011). The 
phosphate: amide I ratio, carbonate: phosphate ratio, carbonate: amide I 
ratio and the amide I: amide III ratio were the parameters investigated. 
They have been used previously in numerous studies for investigations 
of bone disorders (Tarnowski 2002; Kazanci 2007; Buchwald 2012)	  and 
the former three are the most validated markers for bone quality (Morris 
2011). The phosphate: amide I ratio was calculated by dividing the 
height of the phosphate band by the height of the amide I band. The 
carbonate: phosphate ratio was calculated by dividing the height of the 
carbonate band by the height of the phosphate band. The carbonate: 
amide I ratio was calculated by dividing the height of the carbonate band 
by the height of the amide I band. The amide I: amide III ratio was 
calculated by dividing the height of the amide I band by the height of the 
amide III band. The height of the phosphate band was calculated by 
subtracting the average phosphate base (988 – 1000 cm-1) from the 
average phosphate peak (958 – 963 cm-1). The height of the amide I 
band was calculated by subtracting the average amide I base (1701 – 
1705 cm-1) from the average amide I peak (1653 – 1660 cm-1). The 
height of the carbonate band was calculated by subtracting the average 
carbonate base (1108 – 1110 cm-1) from the average carbonate peak 
(1064 – 1071 cm-1). The height of the amide III peak was calculated by 
subtracting the average amide III base (1270 – 1280cm-1) from the 
average amide III peak (1260 – 1265 cm-1). It should be noted that the 
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baseline region for Amide III can include alpha-helix signals as this is 
not a spectrally quiescent region. 
 
3.5 Statistical Analysis Methods 
 
3.5.1 Statistical Methods 
Statistical tests were performed using SPSS Statistics (version 
17.0) software. The sample sizes were insufficient to test for normality 
so the non-parametric equivalents to the t-tests were preferred. The 
Mann Whitney U test was therefore used to compare osteoarthritic 
samples with controls. Moreover, the Wilcoxon Signed Rank test was 
used to compare the different regions within OA and normal tibial 
plateaus. Differences were considered to be statistically significant 
where p < 0.05. The median and inter-quartile range (IQR) was 
considered the most appropriate measure to use for analysis due to the 
v1PO4
-­‐3	  
peak	  
v1CO3
-­‐2	  B-­‐type	  
peak	  
Amide	  I	  
peak	  
Figure 3.6: Typical Raman spectrum of normal subchondral bone with the peaks of 
interest labelled. The Raman intensity (dimensionless) has been normalised to the 
phosphate peak at wavenumber 961cm-1. 
Amide	  III	  peak	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skewed nature of the data. Unless stated otherwise, the data are 
expressed as the median (IQR). 
 
3.5.2 Power Statement 
This study is a pilot study that will explore a number of potential 
outcome measures to identify which is most sensitive and to gain an 
understanding of within patient variability. With 10 OA samples and 10 
normal samples the study will have 80% power to detect a difference of 
1.3 x Standard Deviation (SD) in the outcome measures of interest, 
using the two tailed 5% significance level. An effect size of 1.3 x SD 
constitutes a large effect size, (Cohen 1988). Sample size calculation 
was performed using Stata/IC version 12.1 (StataCorp, College Station, 
TC, USA). 
 
3.5.3 Principal Component Analysis (PCA)  
PCA is a multivariate technique that operates in an unsupervised 
manner and is used to analyze the inherent structure of the data. PCA 
reduces the dimensionality of the data set by finding an alternative set of 
coordinates, the principal components (PC’s) (Martens 1989; Esbensen 
2005). The general form of PCA model is: 
X=TPT +E (1) 
where X matrix is decomposed by PCA into two smaller matrices, one of 
scores (T ) and other of loadings (P ). 
PC’s correspond to a linear combination of the original variables, 
which are orthogonal to each other and constructed in such a way that 
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each one successively accounts for the maximum variability of the data 
set. 
In other words, PCA involves a mathematical procedure that 
transforms a large number of correlated variables (i.e. Raman shifts) 
into a smaller number of uncorrelated variables called principal 
components. Numerically this means that: 
 (2) 
 where ta and tb are the ath and bth columns of T matrix, respectively, and 
 (3) 
where pa and pb are the ath and bth rows of P matrix, respectively. 
The first principal component (PC1) accounts for as much of the 
variability in the data as possible, and each succeeding component 
accounts for as much of the remaining variability as possible. 
When PC-Scores are plotted, for example PC1 vs. PC2 or any 
combination of the PC’s, they can reveal relationships between samples 
(grouping). It is important to remember that PCA does not act in a 
supervised manner, meaning that each number of the groups under 
study is not known a priori. PCA provides insight into the percentage of 
variance explained by each PC and how many PCs should be kept to 
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Raman spectra were acquired via GRAMS software (ver-
sion 3.04, Thermo Galactic, USA). Multivariate data anal-
ysis and pre-processing of data were performed on the Ra-
man spectra, using Origin (version 6.0, MicrocalTM , USA)
and The UnscramblerTM software (version 8.0, CAMO, Nor-
way).
2.3. Multivariate methods
Principal component analysis (PCA) and partial least square-
discriminant analysis (PLS-DA) were performed over the
pre-processed Raman spectra in order to evaluate
(a) the spectral differences among species of microorgan-
isms in the PC space and
(b) to develop models allowing discrimination and classi-
fication among species.
2.3.1. Principal component analysis (PCA)
PCA is a multivariate technique that operates in an unsuper-
vised manner and is used to analyze the inherent structure of
the data. PCA reduces the dimensionality of the data set by
finding an alternative set of coordinates, the principal com-
ponents (PC’s) [18,19]. The general form of PCA model is:
X = TPT + E (1)
whereX matrix is decomposed by PCA into two smaller ma-
trices, one of scores (T ) and other of loadings (P ).
PC’s correspond to a linear combination of the original
variables, which are orthogonal to each other and designed in
such a way that each one successively accounts for the maxi-
mum variability of the data set.
In other words, PCA involves a mathematical procedure
that transforms a large number of correlated variables (i.e.
Raman shifts) into a smaller number of uncorrelated variables
called principal components. Numerically this means that
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where ta and tb are the ath and bth columns of T matrix,
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where pa and pb are the ath and bth rows of P matrix, respec-
tively.
The first principal component (PC1) accounts for as much
of the variability in the data as possible, and each succeeding
component accounts for as much of the remaining variability
as possible.
When PC-Scores are plotted, for example PC1 vs PC2 or
any combination of the PC’s, they can reveal relationships be-
tween samples (grouping). It is important to remember that
PCA does not act in a supervised manner, meaning that each
number of the groups under study is not known a priori. PCA
provides insight into the percentage of variance explained by
each PC and how many PCs should be kept to maintain the
maximum information from the original data without adding
noise to the current information [18,19]. In addition, when
the PC-loadings are plotted as a function of the variables,
the plot reveals the most important diagnostic variables or
regions related with the differences founded in the data set.
2.3.2. Partial least square-discriminant analysis (PLS-DA)
PLS-DA is a version of PLS in which one or several Y-
variables are modeled simultaneously, thus taking advantage
of possible correlations or colinearity between Y-variables.
In PLS, the response matrix X is decomposed in a fashion
similar to PCA, generating a matrix of scores, T, and load-
ings factors, P. (these vectors can also be referred to as basis
vectors)
X = TPT + E (4)
A similar analysis is performed for Y, producing a matrix
of scores, U, and loadings, Q.
Y = UQT + F (5)
The goal of PLS is to model all the constituents forming
X and Y so that the residuals for X block, E, and the residu-
als for Y block, F, are approximately equal to zero. An inner
relationship is also constructed that relates the scores of X
blo k to th scores of the Y block.
U = TW (6)
The above model is improved by developing the so-called
inner relationship. Because latent (basis) vectors are calcu-
lated for both blocks independently, they may have only a
weak relation to each other. The inner relation is improved
by exchanging the scores, T andU, in an iterative calculation.
This allows information from one block to be used to adjust
the orientation of the latent vectors in the other block, and
vice versa. An explanation of the iterative method is avail-
able in the literature [29-31]. Once the complete model is
calculated, the above equations can be combined to give a
matrix of regression vectors, one for each component in Y:
Bˆ = P (PTP )°1WQT (7)
Yˆ = XBˆ (8)
For a discriminant analysis approach, it is assumed that a
sample has to be a member of one of the classes included in
the analysis. Each class is represented by an indicator vari-
able, that is, a binary variable with a value of 1 for members
of the class and 0 for nonmembers. This way, by building
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For a discriminant analysis approach, it is assumed that a
sample has to be a member of one of the classes included in
the analysis. Each class is represented by an indicator vari-
able, that is, a binary variable with a value of 1 for members
of the class and 0 for nonmembers. This way, by building
Rev. Mex. Fı´s. 56 (5) (2010) 378–3 5
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maintain the maximum information from the original data without adding 
noise to the current information. In addition, when the PC-loadings are 
plotted as a function of the variables, the plot reveals the most important 
diagnostic variables or regions related with the differences founded in 
the data set. 
 
3.5.4 Linear Discriminant Analysis (LDA) 
LDA computes linear combinations of variables to determine 
directions in the spectral space, discriminant functions (Linear 
Discriminants, LDs), that maximize the variance between groups and 
minimize the variance within groups according to Fisher’s criterion (Hair 
1998).  
The LDs are used as axes in a scatter plot, to produce a scores 
plot; again relative distances correspond to dissimilarities/similarities in 
the data. A loadings plot may be produced and interpreted to provide 
wavenumbers (and corresponding chemical bonds) responsible for 
segregation between classes.  
 
3.5.5 PCA-LDA 
LDA was performed on the output of data from PCA. This allows 
data reduction, and therefore removal of noise from the dataset prior to 
supervised analysis. 
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CHAPTER 4 – RESULTS  	  
4.0 Baseline Characteristics 
Ten OA, five control fresh and five control cadaveric tibial plateaus 
were analysed. The ten OA samples were from six males and four 
females, the five control fresh samples were from four males and one 
female whereas the five control cadaveric were from five males. Both 
OA and control cadaveric groups had similar ages in the range of 58 – 
88 years. The OA specimens had have average age of 68 years, 
cadaveric specimens had an average age of 74 years, while the fresh 
controls had an average age of 30 years. The difference between the 
age means of the OA and cadaveric specimens was not statistically 
significant (p=0.08) but significantly different when comparing OA and 
fresh controls (p<0.0001) and cadaveric with fresh controls (p<0.0001). 
None of the patients from whom samples were obtained had a known 
clinical history of metabolic bone disease, inflammatory arthritis, cancer, 
history of drug abuse, hepatic or renal pathology. 
 
4.1 Volumetric Bone Mineral Density 
 
4.1.1 Validation Results 
In order to assess repeatability a piece of diaphyseal cadaveric 
human femur sectioned along the coronal plane was used and cortical 
vBMD was calculated at 2 cm intervals along its length. Without 
changing anything another set of measurement was recorded. Five 
measurements were recorded five times in this way. Table 1 gives the 
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average vBMD for each area with standard deviation (this is of the order 
of 1%). 
 REPEATABILITY 
Area 1 1265 mg/cm3 (12) 
Area 2 1301 mg/cm3 (15) 
Area 3 1290 mg/cm3 (14) 
Area 4 1310 mg/cm3 (11) 
Area 5 1295 mg/cm3 (12) 
	  
Table 1: Mean vBMDs for each area tested with standard deviations. 	  
In order to assess reproducibility a piece of diaphyseal cadaveric 
human femur sectioned along the coronal plane was placed on the 
sample stage and vBMD was measured at a location 5 cm from its 
proximal end (position marked). The sample was then removed, and 
subsequently placed back on the stage, so that the measurement was 
repeated on the same area 5 times. The average vBMD (SD) was 1318 
mg/cm3 (14).  
 
4.1.2 Experimental pQCT results 
The median vBMD of OA samples was 112 mg/cm3 higher 
(p<0.001) than the median vBMD of control samples (fresh and 
cadaveric) (Figure 4.1). The middle portion of both the medial and 
lateral tibial plateaus was used to obtain the most representative 
measurements subsequently used for statistical analysis.  Figure 4.2 
highlights differences between OA, control fresh and control cadaveric 
specimens. The median vBMD of OA samples was 52 mg/cm3 higher 
than cadaveric controls (p=0.018) and 187 mg/cm3 higher than fresh 
controls (p=0.001). Figure 4.3 demonstrates differences between OA 
and control medial and lateral tibial plateaus. The median vBMD of OA 
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medial plateaus was 78 mg/cm3 higher than the OA lateral plateaus 
(p=0.005). The median vBMD of OA medial plateaus was 155mg/cm3 
higher than the control medial plateaus (p=0.003). There was no 
statistically significant difference between control medial and control 
lateral plateaus (p=0.241) and no statistically significant difference 
between OA lateral and control lateral plateaus (p=0.059).  
The thickness of the subchondral bone is equal across both 
compartments of the non-OA samples but thicker in the medial 
compartment of the OA specimens (Figure 4.4). 
 
	  
Figure 4.1: Volumetric Bone Mineral Density between osteoarthritic and normal 
(fresh and cadaveric) specimens irrespective of compartment. Measurements 
obtained from the central portion of the medial and lateral tibial plateaus. Median 
values are presented in mg/cm3 to an accuracy of ±5.0mg/cm3. Error bars 
represent the inter-quartile range. 	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Figure 4.2: Volumetric Bone Mineral Density between osteoarthritic, control 
(normal) fresh and control (normal) cadaveric specimens. Osteoarthritic 
specimens are matched for age with control cadaveric. Median values are 
presented in mg/cm3 to an accuracy of ±5.0mg/cm3. Error bars represent the 
inter-quartile range.	  	  
	  
Figure 4.3:  Volumetric Bone Mineral Density between osteoarthritic and control 
medial and lateral tibial plateaus specimens. Median values are presented in 
mg/cm3 to an accuracy of ±5.0mg/cm3. Error bars represent the inter-quartile 
range. 	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Figure 4.4: Bone Thickness between osteoarthritic and control medial and lateral 
tibial plateaus specimens. Median values are presented in mg/cm3 to an 
accuracy of ±0.5mm. OA samples have statistically significant thicker 
subchondral bone in the medial compartment compared to both control medial 
and OA lateral compartments. Error bars represent the inter-quartile range. 	  
	  
Specimen	  
	  
vBMD	  
(mg/cm3)	  
Subchondral	  
bone	  
thickness	  
(mm)	  
Specimen	   vBMD	  (mg/cm3)	  
Subchondral	  
bone	  
thickness	  
(mm)	  
OA	  1	  	   Medial:	  984.5	   3.2	   Control	  (fresh)	  1	   Medial:	  957.2	   1.8	  Lateral:	  916.2	   1.2	   Lateral:	  927.0	   1.8	  OA	  2	  	   Medial:	  841.2	   3.3	   Control	  (fresh)	  2	   Medial:	  720.7	   1.1	  Lateral:	  810.0	   1.3	   Lateral:	  737.2	   1.1	  
OA	  3	   Medial:	  956.1	   4.9	   Control	  (fresh)	  3	   Medial:	  690.2	   1.2	  Lateral:	  869.3	   1.5	   Lateral:	  703.0	   1.2	  OA	  4	  	   Medial:	  988.6	   2.5	   Control	  (fresh)	  4	   Medial:	  820.1	   1.1	  Lateral:	  914.2	   1.4	   Lateral:	  818.0	   1.1	  
OA	  5	   Medial:	  997.4	   3.2	   Control	  (fresh)	  5	   Medial:	  746.2	   1.2	  Lateral:	  950.0	   1.7	   Lateral:	  752.3	   1.2	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OA	  6	   Medial:	  1186.2	   2.7	   Control	  (cadaveric)	  1	   Medial:	  843.7	   1.1	  Lateral:	  857.1	   2.0	   Lateral:	  833.1	   1.1	  
OA	  7	   Medial:	  1052.3	   2.6	   Control	  (cadaveric)	  2	   Medial:	  957.0	   1.3	  Lateral:	  904.5	   1.4	   Lateral:	  928.6	   1.3	  
OA	  8	   Medial:	  928.1	   1.6	   Control	  (cadaveric)	  3	   Medial:	  723.1	   1.5	  Lateral:	  874.9	   1.3	   Lateral:	  718.2	   1.5	  
OA	  9	   Medial:	  1184.5	   2.3	   Control	  (cadaveric)	  4	   Medial:	  887.2	   1.0	  Lateral:	  950.3	   1.3	   Lateral:	  869.9	   1.0	  
OA	  10	   Medial:	  956.0	   3.7	   Control	  (cadaveric)	  5	   Medial:	  903.0	   1.4	  Lateral:	  912.7	   1.4	   Lateral:	  895.3	   1.4	  	  
Table 2: vBMD and subchondral bone thickness in individual OA and control 
samples. Values represent single measurements taken from the central portion 
of the corresponding half of the tibial plateau. 	  	  
Figure 4.5 illustrates the differences in the appearance of typical 
pQCT scans from control and OA tibial plateaus respectively. 	  	  	  	  
 
 
Figure 4.5: (a) left – typical appearance of pQCT from normal tibial plateau (sagittal 
section; posterior to anterior). Note the thickness of the normal articular cartilage (grey 
area) (b) right – typical appearance of pQCT from osteoarthritic tibial plateau (sagittal 
section; posterior to anterior). Note how thin the articular cartilage is and compare with 
(a) (grey area). Small yellow squares (arrows) demarcate area of interest wherefrom 
density measurement is obtained. 	  
1 cm scale 
	   93	  
4.2 Raman Spectroscopy 
 
4.2.1 Validation Results 
In order to assess repeatability ten repeated spectra from the 
same location of a sample were recorded, pre-processed and plotted 
together (Figure 4.6). It can be seen that the variation is very small 
between each measurement and that the amide I band does not change 
shape. The average phosphate/amide I, carbonate/amide I and 
carbonate/phosphate ratios are given in Table 3, the standard deviation 
for each ratio is of the order of 1%. 
	  
Figure 4.6: Ten spectra recorded one after another on the same piece of bone. 	  
 REPEATABILITY 
Phosphate/Amide I 13.2(0.2) 
Carbonate/Amide I 2.1(0.1) 
Carbonate/Phosphate 0.15(0.001) 
 
Table 3: The mean ratios (standard deviation) for phosphate/amide I; 
carbonate/amide I; carbonate/phosphate are shown. 
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In order to assess reproducibility a spectrum was recorded from a 
specimen (cadaveric femur), the sample was then removed, and 
subsequently placed back on the stage, so that the laser illuminated 
roughly the same area, and another spectrum was recorded. Ten 
spectra were obtained this way. Since it was impossible to probe the 
exact same piece of bone material, the variation between these plots 
was larger that in repeatability measurements. However the spectra 
were again very similar and the amide I band did not change shape. 
Band ratios are given in Table 4. 
 REPRODUCIBILITY 
Phosphate/Amide I 12.9(0.3) 
Carbonate/Amide I 2.2(0.2) 
Carbonate/Phosphate 0.17(0.002) 	  
Table 4: The mean ratios (standard deviation) for phosphate/amide I; 
carbonate/amide I; carbonate/phosphate are shown. 
 
4.2.2 Raw Spectral Signatures 
The Raman spectra from each cohort were averaged and 
compared (Figures 4.7 to 4.14). Ten independent spectra were 
acquired per core, therefore 20 spectra per tibial plateau (total 400 
spectra). By eye there are few differences between the OA and non-OA, 
however, subtle differences are difficult to identify by observing only the 
average spectra from each data set. To improve discrimination 
multivariate analysis was required to quantify the subtle differences 
across the spectrum as a whole. The main biological peaks of interest 
are shown in the following figures and include phosphate (960 cm-1), 
Amide I (≈1660 cm-1), Amide III (≈1275 cm-1) and carbonate (1070 cm-1). 
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Figure 4.7: Mean Spectra (20 spectra per tibial plateau) for osteoarthritic 
compared to control/normal (fresh and cadaveric) tibial plateaus. Small 
differences can be identified by naked eye at the carbonate and amide peaks. 
The Raman intensity (a.u.) has been normalised to the phosphate peak at 
wavenumber 961cm-1. 
 
	  
Figure 4.8: Mean Spectra (20 spectra per tibial plateau) for osteoarthritic 
compared to fresh control (normal) tibial plateaus. Differences predominantly 
seen at amide peaks. The Raman intensity (dimensionless) has been normalised 
to the phosphate peak at wavenumber 961cm-1.  
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Figure 4.9: Mean Spectra (20 spectra per tibial plateau) for osteoarthritic 
compared to cadaveric control (normal) tibial plateaus. Main difference, for the 
biological peaks of interest, is seen by naked eye at carbonate peak. The Raman 
intensity (dimensionless) has been normalised to the phosphate peak at 
wavenumber 961.36cm-1. 	  
	  
Figure 4.10: Mean Spectra (20 spectra per tibial plateau) for fresh control 
(normal) compared to cadaveric control (normal) tibial plateaus. Differences 
observed in carbonate, amide I and amide III peaks. The Raman intensity 
(dimensionless) has been normalised to the phosphate peak at wavenumber 
961.36cm-1. 
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Figure 4.11: Mean Spectra (10 spectra per tibial plateau compartment) for 
osteoarthritic medial compared to osteoarthritic lateral tibial plateaus. No 
detectable difference by naked eye. The Raman intensity (dimensionless) has 
been normalised to the phosphate peak at wavenumber 961.36cm-1. 	  
	  
Figure 4.12: Mean Spectra (10 spectra per tibial plateau compartment) for control 
(fresh) medial compared to control (fresh) lateral tibial plateaus. No detectable 
difference by naked eye. The Raman intensity (dimensionless) has been 
normalised to the phosphate peak at wavenumber 961.36cm-1. 
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Figure 4.13: Mean Spectra (10 spectra per tibial plateau compartment) for control 
(cadaveric) medial compared to control (cadaveric) lateral tibial plateaus. No 
detectable difference by naked eye. The Raman intensity (dimensionless) has 
been normalised to the phosphate peak at wavenumber 961.36cm-1. 	  
	  
Figure 4.14: Mean Spectra (20 spectra per tibial plateau) for osteoarthritic 
compared to fresh control and cadaveric control tibial plateaus. Predominant 
difference, for the biological peaks of interest, is observed in relation to amide I 
peak. The Raman intensity (dimensionless) has been normalised to the 
phosphate peak at wavenumber 961.36cm-1. 
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4.2.3 Mineral Volume Ratios determined by the Phosphate to Amide 
I Peak Magnitude Ratio (level of mineralisation) – Univariate 
Analysis 
There was no statistically significant difference between OA lateral 
and OA medial tibial plateaus (p=0.08). Moreover, there was no 
difference when comparing control medial to control lateral. Figures 
4.15 to 4.16 summarise the comparisons in terms of the degree of 
mineralisation for the various specimen combinations. Table 5 
summarises the statistical significance values for the various 
comparisons. 
Comparison Phos:amide 
OA (l+m) vs. N (l+m) 0.04 
OA l vs. N l 0.005 
OA m vs. N m 0.04 
OA l vs. OA m 0.08 
N l vs. N m 0.281 
 
Table 5: Statistical significance values for phosphate: amide I ratio comparisons. 
OA=osteoarthritic; N=normal (fresh and cadaveric together); l=lateral; m=medial 
 
When comparing lateral tibial plateaus and medial tibial plateaus 
separately between osteoarthritic samples and control (fresh and 
cadaveric combined) there was a statistically significant difference  
(p=0.005 and p=0.04 respectively) with higher phosphate to amide I 
ratio in the OA groups; a comparison of the entire tibial plateau (medial 
and lateral compartments together) between OA and controls (cadaveric 
and fresh together) also demonstrated statistical significance (p=0.04) 
with a lower ratio in the control group.  
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Figure 4.15: Phosphate: Amide I ratio in osteoarthritic and control (normal; fresh 
and cadaveric) medial and lateral tibial plateaus. The Phosphate: Amide I ratio 
indicates the degree of mineralisation. Median ratios (dimensionless) are 
presented to an accuracy of two decimal places. Error bars represent the inter-
quartile range. p values are given only for the statistically significant 
comparisons.	  
Figure 4.16: Phosphate: Amide I ratio in osteoarthritic and normal (fresh and 
cadaveric) tibial plateaus irrespective of laterality. The Phosphate: Amide I ratio 
indicates the degree of mineralisation. Median ratios (dimensionless) are 
presented to an accuracy of two decimal places. Error bars represent the inter-
quartile range. Significant difference observed between OA and normal tibial 
plateaus irrespective of compartment. 
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4.2.4 Carbonate to Phosphate Ratio as Indicative of Carbonate 
Substitution – Univariate Analysis 
There was no statistically significant difference in the extent of 
carbonate substitution in the lattice structure of the apatite crystals, 
between OA lateral and OA medial tibial plateaus (p=0.6) and control 
(fresh and cadaveric) medial and control lateral tibial plateaus (p=0.3). 
Table 6 summarises the statistical significance values for the various 
comparisons. 
 
Comparison Carb:Phos 
OA (l+m) vs. N (l+m) p<0.001 
OA l vs. N l 0.016 
OA m vs. N m p<0.001 
OA l vs. OA m 0.6 
N l vs. N m 0.3 
 
Table 6: Statistical Significance Values for carbonate to phosphate ratio 
comparisons. OA=osteoarthritic; N=normal (fresh and cadaveric together); 
l=lateral; m=medial 
 
Carbonate substitution was lower in osteoarthritic samples 
compared to controls (fresh and cadaveric combined) with a statistically 
significant difference between the lateral tibial plateaus (p=0.016), 
medial tibial plateaus (p<0.001) and entire tibial plateaus (irrespective of 
laterality) (p<0.001).  
Figures 4.17 and 4.18 summarise the comparisons in terms of the 
extent of carbonate substitution in the lattice structure of the apatite 
crystals. 
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Figure 4.17: Carbonate to Phosphate ratio in osteoarthritic and control (fresh 
and cadaveric) medial and lateral tibial plateaus. The Carbonate to Phosphate 
ratio indicates the extent of carbonate substitution in the apatite crystals. 
Median ratios (dimensionless) are presented to an accuracy of two decimal 
places. Error bars represent the inter-quartile range. OA specimens exhibit lower 
carbonate substitution hence greater degree of mineralisation.	  
 
Figure 4.18: Carbonate to Phosphate ratio in osteoarthritic and control (fresh 
and cadaveric) tibial plateaus irrespective of compartment. The Carbonate to 
Phosphate ratio indicates the extent of carbonate substitution in the apatite 
crystals. Median ratios (dimensionless) are presented to an accuracy of two 
decimal places. Error bars represent the inter-quartile range. Controls exhibit 
greater carbonate substitution compared to OA.	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4.2.5 Carbonate to Amide I Ratio as Indicator of Remodelling – 
Univariate Analysis 
Carbonate to amide I ratio has been suggested as a potential 
marker for bone remodelling (McCreadie et al. 2006). There was no 
significant difference between OA lateral and OA medial tibial plateaus 
and control (fresh and cadaveric) medial to control lateral. Table 7 
summarises the statistical significance values for the various 
comparisons. 
Comparison Carb:Amid 
OA (l+m) vs. N (l+m) p<0.001 
OA l vs. N l p<0.001 
OA m vs. N m 0.009 
OA l vs. OA m 0.058 
N l vs. N m 0.927 
 
Table 7: Statistical Significance Values for carbonate to amide I ratio 
comparisons. OA=osteoarthritic; N=normal (fresh and cadaveric together); 
l=lateral; m=medial 
 
When comparing osteoarthritic samples to controls (fresh and 
cadaveric combined), carbonate to amide I ratio was higher in the OA 
cohort with a statistically significant difference between the lateral tibial 
plateaus (p<0.001), medial tibial plateaus (p=0.009) and entire tibial 
plateaus (irrespective of laterality) (p<0.001).  
Figures 4.19 and 4.20 summarise the comparisons in terms of the 
degree of bone remodelling for the various specimen combinations. 
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Figure 4.19: Carbonate to Amide I ratio (may indicate bone remodelling) in 
osteoarthritic and control (fresh and cadaveric) medial and lateral tibial plateaus. 
Median ratios (dimensionless) are presented to an accuracy of two decimal 
places. Error bars represent the inter-quartile range. OA demonstrates higher 
carbonate to amide I ratio compared to controls (fresh and cadaveric combined).	  
Figure 4.20: Carbonate to Amide I ratio (may indicate bone remodelling) in 
osteoarthritic and control (fresh and cadaveric) tibial plateaus irrespective of 
laterality. Median ratios (dimensionless) are presented to an accuracy of two 
decimal places. Error bars represent the inter-quartile range. Carbonate to amide 
I ratio is higher in the OA cohort compared to the control cohort irrespective of 
compartment.	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4.2.6 Amide I to Amide III Ratio as Indicator of Collagen’s 
Secondary Structure – Univariate Analysis 
The collagen quality parameter used in Raman spectroscopy 
investigates the collagen’s secondary structure and the degree of 
distortion of collagen crosslinks in bone matrix. This parameter could be 
obtained by studying the amide I or amide III envelopes(Morris 2011). 
Overall amide I or amide III envelope analysis should be used with 
caution.  In our study we used amide I to amide III ratio as a potential 
indicator of collagen secondary structure.  
There was no significant difference between OA lateral and OA 
medial tibial plateaus and between control (fresh and cadaveric) medial 
and control lateral. Table 8 summarises the statistical significance 
values for the various comparisons. 
Comparison Amide I:Amide III 
OA (l+m) vs. N (l+m) p<0.001 
OA l vs. N l p<0.001 
OA m vs. N m p<0.001 
OA l vs. OA m 0.097 
N l vs. N m 0.706 
 
Table 8: Statistical Significance Values for amide I to amide III ratio 
comparisons. OA=osteoarthritic; N=normal (fresh and cadaveric together); 
l=lateral; m=medial 
 
 
When comparing osteoarthritic samples to controls (fresh and 
cadaveric combined) there was a statistically significant difference, with 
higher ratio in OA samples, between the lateral tibial plateaus 
(p<0.001), medial tibial plateaus (p<0.001) and entire tibial plateaus 
(irrespective of laterality) (p<0.001).  
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Figures 4.21 to 4.22 summarise the comparisons in terms of 
amide I to amide III ratios for the various sample combinations. 
Figure 4.21: Amide I: Amide III ratio (potential marker of collagen I secondary 
structure) in osteoarthritic and control (fresh and cadaveric) medial and lateral 
tibial plateaus. Median ratios (dimensionless) are presented to an accuracy of 
two decimal places. Error bars represent the inter-quartile range. Higher ratio 
seen in OA when compared to controls (combined fresh and cadaveric). 	  
Figure 4.22: Amide I: Amide III ratio (potential marker of collagen I secondary 
structure) in osteoarthritic and control (fresh and cadaveric) tibial plateaus 
irrespective of laterality. Median ratios (dimensionless) are presented to an 
accuracy of two decimal places. Error bars represent the inter-quartile range. 
Higher ratio in the OA cohort compared to the control cohort.	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4.3 Multivariate Analysis 
Multivariate analysis was performed on the Raman spectral data 
sets, with the aim of identifying, in an unsupervised (PCA) and 
supervised (LDA) manner, the similarities and differences inherent in the 
spectra.  
 
4.3.1 PCA 
Figures 4.23 and 4.24 depict the PCA-scores plot obtained from 
the multivariate analysis, looking at all specimens. A 3D scatter plot of 
the scores (a scores plot) allows for differences to be identified because 
the distance between the scores (points; each point represents a 
spectrum) on the plot directly relate to the biochemical similarities, i.e., 
the closer together two scores are in the plot the more similar they are 
biochemically and vice versa.  Figure 4.23 demonstrates separation 
between OA group and control group (fresh and cadaveric combined). 
Figure 4.24 shows the spread of the data and reveals that the OA, 
control (normal) fresh and control (normal) cadaveric separate into three 
distinct groups with little overlap. The reasons for the spectral 
differences resolved from PCA are identified from interpretation of 
Figure 4.25 (corresponding to PCA of Figure 4.23) and Figure 4.26 
(corresponding to PCA of Figure 4.24). The first axis (PC1) shows that 
the phosphate band (954 and 966 cm-1) is different between all the 
cohorts. In Figure 4.25, PC2 reveals that the second largest difference 
between the groups is Amide I (1668 and 1685 cm-1) and phosphate 
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shoulder (941 cm-1); PC3 shows that the next difference is related to 
broad differences across ~1597 cm-1.  	  
	  
	  
Figure 4.23: 3D –PCA score plot of non –OA vs. OA. 
Figure 4.24: 3D - PCA score plot for control (normal – fresh), control (normal – cadaveric) and 
osteoarthritic specimens. 
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Figure 4.27 depicts the PCA-score plot of PC1 vs. PC2 vs. PC3 
obtained from the multivariate analysis, looking specifically at normal 
Figure 4.25: PCA loadings for control (fresh and cadaveric) vs. osteoarthritic specimens. 
Figure 4.26: PCA loadings for control (fresh) vs. control (cadaveric) vs. OA. 
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fresh vs. normal cadaveric tibial plateaus. Despite some overlap, a 
separation among specimens can be observed along the PC1-axis. In 
Figure 4.28 the PC-loading values are plotted, which represent the 
regions of the Raman spectra where the differences among cohorts are 
more evident. The main difference relates predominantly to the 
phosphate peak (954 and 966 cm-1) and this is smaller compared to the 
one observed in Figure 4.25 
	  
Figure 4.27: 3D - PCA score plot for normal fresh and normal cadaveric 
specimens. 	  
	  
Figure 4.28: PCA loadings for normal fresh and normal cadaveric specimens. 
The main difference relates predominantly to the phosphate peak (954 and 966 
cm-1). 
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4.3.2 PCA – LDA  
Figure 4.29 presents the PCA-LDA scores of all the specimens 
analysed. The formation of three clusters is observed, corresponding to 
normal fresh, normal cadaveric and osteoarthritic tibial plateaus. While 
the cluster of the normal cadaveric tibial plateaus is well separated, 
some overlapping between the normal fresh and the osteoarthritic tibial 
plateaus is observed. Furthermore, if you consider the fresh and 
cadaveric to be one cluster there is good separation from the OA 
cluster. Figure 4.30 depicts the loadings plot for the PCA-LDA analysis 
and represents the regions of the Raman spectra where the differences 
among specimens can be identified. Interpretation of Figure 4.30 shows 
that the main differences among the tibial plateaus analyzed are 
localized in the 900- 980 cm-1 region. 
	  
Figure 4.29: PCA-LDA scores plot for osteoarthritic, normal cadaveric and 
normal fresh specimens. The formation of three clusters is observed. While the 
cluster of the normal cadaveric tibial plateaus is well separated, some 
overlapping between the normal fresh and the osteoarthritic tibial plateaus is 
observed. 	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Figure 4.30: PCA-LDA loadings plot for osteoarthritic, normal fresh and normal 
cadaveric specimens. The main differences among the tibial plateaus analyzed 
are localized in the 900- 980 cm-1 region. 	  
Figure 4.31 is a PCA-LDA scores plot for medial and lateral 
compartments of non-OA and OA specimens. It emphasises the 
differences between non-OA and OA while confirming that there are no 
differences between compartments within each cohort, as previously 
seen with the univariate analysis. 
	  
Figure 4.31: PCA-LDA scores plot for non-OA medial vs. non-OA lateral vs. OA 
medial vs. OA lateral. 
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4.4 Collagen Alpha Chain Analysis 
Figures 4.32 to 4.37 display the individual bands obtained from 
electrophoresis. The difference in the α1-chain to α2-chain ratios 
between OA and normal samples was found to be statistically significant 
(p = 0.021) with the OA samples showing higher α1-chain to α2-chain 
ratio. The OA samples had a median α1-chain to α2-chain ratio of 3.05:1 
(IQR 3.95:1 – 2.4:1), which is above the normal ratio level for 
heterotrimeric collagen of two alpha 1 to one alpha 2 (standard 2.476:1). 
The maximum OA ratio analysed was 11.5:1 and the minimum 1.8:1. On 
the other hand, the pooled normal samples had a median α1-chain to 
α2-chain ratio of 1.75:1 (IQR 3.17:1 – 1.42:1). The maximum normal 
ratio analysed was 5.9:1 and the minimum 1.4:1.  
Comparisons of the α1-chain to α2-chain ratios between the 
medial and lateral sides of the OA tibial plateaus found no significant 
difference. However both medial and lateral mean ratios were above the 
normal level for heterotrimeric collagen of 2:1 (standard 2.476:1) at 
4.087:1 and 3.573:1 respectively (p>0.05).  	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Figure 4.32: SDS PAGE bands. From left to right: molecular weight standard, 
collagen standard, OA specimen 1 medial (3.3:1), OA specimen 1 lateral (3.8:1), 
OA specimen 2 medial (3.7:1), OA specimen 2 lateral (3.1:1), OA specimen 3 
medial (9.4:1). 	  
	  
Figure 4.33: SDS PAGE bands. From left to right, OA specimen 5 lateral (2.6:1), 
OA specimen 5 medial (4.8:1), OA specimen 4 lateral (2.2:1), OA specimen 4 
medial (3.3:1), OA specimen 3 lateral (11.5:1), molecular weight standard, 
collagen standard. 	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Figure 4.34: SDS PAGE bands. From left to right: OA specimen 8 medial (4.0:1), 
OA specimen 7 lateral (3.0:1), OA specimen 7 medial (1.8:1), OA specimen 6 
lateral (2.4:1), OA specimen 6 medial (6.4:1) collagen standard, molecular weight 
standard. 
	  
	  
	  
Figure 4.35: SDS PAGE bands. From left to right: collagen standard, molecular 
weight standard, OA specimen 8 lateral (1.9:1), OA specimen 9 medial (2.4:1), OA 
specimen 9 lateral (2.7:1), OA specimen 10 medial (1.8:1), OA specimen 10 lateral 
(2.6:1). 
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Figure 4.36: SDS PAGE bands. From left to right: molecular weight standard, 
collagen standard, normal fresh specimen 1 medial, normal fresh specimen 1 
lateral (1.4:1), normal fresh specimen 2 medial (1.8:1), normal fresh specimen 2 
lateral (2.2:1), normal fresh specimen 3 lateral (3.5:1). 	  
	  
Figure 4.37: SDS PAGE bands. From left to right: normal fresh specimen 4 lateral 
(5.9:1), normal fresh specimen 5 medial (1.5:1), normal fresh specimen 5 lateral 
(1.7:1), molecular weight standard, collagen standard, normal fresh specimen 1 
lateral repeat (1.4:1). 	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Figure 4.38 summarises the comparison between the OA and 
normal tibial plateaus. 	  
	  
Figure 4.38: a1: a2 chain ratio between the osteoarthritic and normal (fresh and 
cadaveric) tibial plateaus. Median ratios (dimensionless) are presented to an 
accuracy of two decimal places. Error bars represent the inter-quartile range. 
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CHAPTER 5 – DISCUSSION  
5.0 Overview 
Osteoarthritis (OA) is a chronic, slowly progressive, degenerative 
joint disease, leading to pain and disability. It is characterized by the 
degeneration of the articular cartilage and changes in the structure of 
calcified cartilage and underlying subchondral bone. There are several 
proposed pathogenetic mechanisms, attempting to explain the initiation 
of OA. One of them considers that bone may be the primary organ 
triggering OA, with stiffening of the subchondral bone leading to a 
decrease in shock absorbency and eventually cartilage damage due to 
overloading.  
Spectroscopic methods including infrared and Raman 
spectroscopy have been used to study cartilage and bone tissue. They 
give information about the structure and composition of studied material 
at the molecular level, data are obtained in a noninvasive manner or 
minimally invasive method and there is no limit to the size, allowing a 
study of a large area of a sample. Properties of Raman spectroscopy 
(micro-Raman spectroscopy) that make it more attractive than infrared 
spectroscopy for direct analysis of biological tissues include high spatial 
resolution (0.5 to 1 µm) and limited spectral interference from water. 
Better understanding of the role of subchondral bone in OA 
disease progression, through examination of compositional and 
structural changes, is very important in analyzing the etiology of arthritis, 
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developing novel therapeutic targets and monitoring treatment in 
patients. Raman spectroscopy may help by providing insight into the 
chemistry of the subchondral bone and hence its contribution to the 
pathogenesis of OA. This technology has the potential to be used as a 
minimally invasive method to interrogate the inorganic and organic 
phases of bone matrix in patients. The goal of this work was to examine 
the chemical composition and molecular structure of extracellular matrix 
in subchondral bone from human osteoarthritic tibias using Raman 
spectroscopy.  
 
5.1 Volumetric Bone Mineral Density  
 
5.1.1 Appraisal of pQCT Method 
The software used was designed to take into account the porosity 
and structure of the trabeculae and so even if the quality was the same 
between two regions, the vBMD would be different if one region was 
more porous than the other. Moreover, the apparent vBMD was 
measured. This is the wet weight divided by the total volume occupied 
by bone and pore spaces. A more accurate and valid measure of vBMD 
is ash density which is ash weight divided by the actual volume of bone 
tissue(Johanson 1993). The reproducibility of the regions of interest is 
also a limitation. Neither the area nor the dimensions of the rectangular 
regions of interest are specified in the software. Instead, each region of 
interest had to be re-drawn and matched in terms of size as closely as 
possible to the previous one. Slight differences in the size of the 
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rectangles are inevitable and this will have led to subtle differences in 
the vBMD. Moreover, the tibial plateaus were of different sizes, some 
larger than others. Consequently, there was no way of ensuring that 
regions of interest corresponded to an exact location in each specimen.  
 
5.1.2 Discussion of pQCT Results 
The vBMD is greater in OA specimens than controls; the 
subchondral sclerosis, which occurs in OA, could account for this 
increase. The thickness of the subchondral bone, as expected, is equal 
across both compartments of the control samples but thicker in the 
medial compartment of the OA specimens (p < 0.001) compared to the 
lateral compartment.  
The variation of bone mineral density in OA subchondral bone 
was considerable. This was illustrated by a relatively large IQR error 
bar. It would be worthwhile to investigate whether this variation is linked 
to the severity of OA. The results are consistent with the hypothesis and 
what has been established from previous studies. Dequeker and Johnell 
found an increase in bone density in OA and suggested that this is 
protective against hip fractures(Dequeker 1993). Jones et al. also found 
an increase in bone density in OA but were sceptical as to whether this 
provides a protective function(Jones 1995). Moreover, the differences in 
vBMD between individual OA specimens were found to be insignificant 
(p=0.745) despite their differences in age, sex, severity of OA, loading 
history and so on. All of these factors potentially could have been major 
confounders but the statistical insignificance allows us to assume their 
impact on the data is limited.  
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Despite the results confirming previous reports, one puzzling 
question still remains: vBMD measures the mineral density and 
hypomineralisation has been found in OA, why then is the vBMD higher 
in OA than controls? This apparent contradiction can be explained by 
distinguishing apparent structural density from material density. The 
apparent density of bone is the wet weight divided by the total volume 
occupied by bone and pore spaces(Johanson 1993). The total volume 
increases in OA by 10-15% because of a thickening of the trabeculae(Li 
1997). This is identified radiologically as subchondral sclerosis. 
However, Grynpas et al. measured the mineral content in bone through 
density fractionation, and found the OA subchondral bone (both the 
cortical plate and the underlying cancellous bone) to contain less 
mineral content than age-matched controls(Grynpas 1991). Therefore, 
from a material perspective, and contrary to intuition, bone mineral 
density actually decreases in OA. Why does it decrease? Burr suggests 
subchondral bone is constantly remodeling (in a damage and repair 
cycle) with a high turnover rate, preventing the matrix from fully 
mineralising(Burr 2004). Consequently, subchondral bone has a lower 
material density in OA so the total volume, which is related to the 
apparent density, must increase significantly to provide a sufficient 
degree of stiffness. Therefore, the apparent structural density has to 
increase in OA, to compensate for the reduced material density, in order 
to provide an acceptable level of structural stiffness(Burr 2004). 
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5.1.3 Summary for Volumetric Bone Mineral Density and Wider 
Implications 
1. The thickness of the subchondral bone is equal across both 
compartments of the non-OA samples but thicker in the medial 
compartment of the OA specimens. 
2.  The subchondral bone in the medial compartment is statistically 
significantly denser than the lateral compartment. These 
measurements of the bone are taking into account the bone as a 
material and a structure. 
3. The OA medial compartments are thicker and denser than the 
lateral and overall denser than the non-OA specimens.  
 
5.2 Raman Spectroscopy 
 
5.2.1 Appraisal of Raman Spectroscopy Method 
Ratio parameters were used instead of absolute band intensities 
because the latter is affected by the efficiency of Raman scattering, the 
refractive index and the surface roughness (Morris 2011). The ratios 
were calculated by using the actual heights of the bands. A better 
technique would have been to use the areas of the bands. The area of a 
particular band could be obtained by fitting a Gaussian curve(Morris 
2011). The ratio parameters used were carefully considered before 
selection. There is evidence to suggest that the carbonate to amide I 
ratio may reflect bone remodelling (McCreadie 2006) but more validation 
is required. The amide I band was also used to represent the matrix in 
the mineral to matrix ratio. According to Morris, an informal consensus is 
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forming around the use of proline and hydroxyproline bands as a more 
accurate measure of matrix content(Morris 2011; Karampas 2012). 
However, further validation is still required. Equally there is no 
consensus in the literature as to the best way of assessing collagen 
secondary structure. In this study we used the amide I to amide III ratio 
as a potential marker of collagen differences between cohorts, however 
this is not validated in the literature. The technique used to baseline 
correct the data has some flaws(Schulze 2005). There are newer and 
perhaps better ways to baseline correct the data so as to account for 
fluorescence. Zhang et al. have recently developed a novel algorithm 
that does not require user intervention(Zhang 2010). 
Finally laser polarization and orientation of the specimen can 
potentially have an effect on the spectra acquired. In this work all 
specimens were orientated in a given way with no variations during 
measurements, however the absolute effect of different specimen 
orientations was not formally assessed.  
 
5.2.2. Discussion of Spectroscopy Results 
 
5.2.2.1 Mineral Volume Ratios Determined by the Phosphate to 
Amide I Peak Magnitude Ratio (level of mineralisation) 
The phosphate to amide I ratio indicates the degree of 
mineralisation. The levels of mineralisation were not significantly greater 
in OA medial (macroscopically affected) compared to OA lateral 
(macroscopically normal) tibial plateaus but were significantly higher 
when the whole OA specimen was compared to the control tibial 
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plateaus (fresh and cadaveric together) as well as when comparison 
was between OA cohort and control fresh and OA and control cadaveric. 
These findings disagree with the hypothesis and contradict the literature 
suggesting that OA subchondral bone is in fact hypermineralised. 
The majority of the literature suggests OA bone should be 
hypomineralised. Mansell and Bailey found lower levels of 
mineralisation in OA(Mansell 1998). Although the phosphate to amide I 
ratio has been used and validated in previous studies(Morris 2011), 
there may be other bands in the spectra that reflect the matrix content 
better than the amide I band. Buchwald et al. used the phosphate to 
amide III band as an indicator of mineralisation ratio and found OA 
subchondral bone to be less mineralised than controls(Buchwald 2012). 
They concluded that hypomineralisation of OA subchondral bone was a 
consequence of increased turnover and remodelling. Furthermore, 
Grynpas et al. found that despite an increased thickness, the 
subchondral cortical plate in OA was deficient in mineral(Grynpas 1991). 
Ageing is known to increase mineral content and can therefore influence 
the mineral to matrix ratio(Grynpas 1991). One could therefore argue 
that the observed difference between the OA specimens and the control 
fresh specimens could be a result of ageing, given that the control fresh 
cohort had a lower mean age compared to the OA cohort. This however 
does not explain the difference between OA and control cadaveric; two 
cohorts that were age matched.  
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5.2.2.2 Carbonate to phosphate ratio as indicative of carbonate 
substitution 
The carbonate to phosphate ratio reflects the extent of carbonate 
accumulation in the apatite crystals. Carbonate accumulation was 
significantly lower in OA subchondral bone than controls. This was the 
case when comparing the OA cohort with the control cohort (fresh and 
cadaveric combined). Comparison of the medial to the lateral tibial 
plateau in OA specimens did not demonstrate a statistically significant 
decrease. 
It is believed that carbonate substitution into the apatite crystals 
increases as a response to a decline in mineralization(Buchwald 2012). 
Carbonate ions may replace phosphate ions in apatite crystals as an 
attempt to limit mineral loss. These findings further support the 
hypermineralisation found in OA subchondral bone.  
Putting the results so far together, they suggest the presence of 
hypermineralisation in OA subchondral bone with high levels of 
phosphate and low levels of carbonate in the apatite crystals. The 
findings do not support the hypothesis. The lower levels of carbonate 
accumulation in OA were unexpected. Buchwald et al. found carbonate 
accumulation to be significantly higher in OA subchondral bone than 
controls(Buchwald 2012).  
 
5.2.2.3 Carbonate to Amide I Ratio as Indicator of Remodeling  
It has been suggested that the carbonate to amide I ratio is a 
marker for bone remodeling(McCreadie 2006). The carbonate to amide I 
ratio was significantly higher in osteoarthritic subchondral bone when 
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compared to controls (fresh and cadaveric combined). The results 
suggest that bone remodeling is higher in OA than controls. This is 
consistent with the literature. Woods et al. found similar carbonate to 
amide I ratios in OA specimens(Woods 2011). Grynpas et al. discovered 
increased levels of bone remodeling in the weight-bearing regions of OA 
subchondral bone compared to non-weight bearing regions(Grynpas 
1991). Furthermore, Mansell and Bailey also found OA bone to be more 
metabolically active than controls, and the rate of turnover to decrease 
distally(Mansell 1998). The polarisation in OA bone turnover could 
precipitate joint deformity as the levels of bone remodeling can influence 
the morphology. Indeed, knee joint deformity is regularly seen in end-
stage OA. Joint deformity could aggravate the disease process by 
increasing the stress on subchondral bone. 
The increase in subchondral bone turnover in OA is not due to a 
remodeling of microfractures (Burr 2004), as first envisaged by Radin 
and Rose(Radin 1986). Burr proposes that microcracks, instead of 
microfractures, may play a physiological role. Mechanically overloading 
the joint may result in microcracks, which disrupt the canalicular 
processes resulting in apoptosis of osteocytes. This brings the 
continuous release of sclerostin by osteocytes to a halt. This somehow, 
for reasons not completely understood, stimulates bone remodeling. 
Perhaps, when the inhibitory effect of sclerostin is lost, osteoblasts can 
express RANKL on their cell-surface. RANKL can bind to RANK, which 
is on the surface of osteoclast-precursor cells. This interaction 
stimulates the latter to differentiate into mature osteoclasts, which can 
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then resorb bone. Indeed, osteoclasts are seen leading the cutting 
cones and residing in resorption pits. They help remove microcracks 
and eventually the damage is repaired by osteoid-secreting osteoblasts. 
Therefore, the presence of microcracks in OA results in an increased 
rate of subchondral bone turnover, which in turn, leads to a decrease in 
the material density(Burr 2004). 
 
5.2.2.4 Amide I to Amide III as indicator of collagen’s secondary 
structure 
Diagnosis and monitoring of collagen defects poses a challenge, 
especially for sub-clinical patients, since several inter-related 
biochemical, environmental and genetic factors may lead to collagen 
damage. Genetic and acquired abnormalities in types I, II and IX 
collagen cause a range of skeletal diseases, such as early-onset 
osteoarthritis, Stickler’s syndrome and osteogenesis imperfecta (OI) 
Amide I to amide III ratio was used in this study as a potential 
marker of collagen I secondary structure. When comparing osteoarthritic 
samples to normal (fresh and cadaveric combined) there was a 
statistically significant difference with a higher ratio in the OA group. 
This can potentially and cautiously be interpreted as a reflection of 
collagen differences between the OA and control groups. 
Raman spectroscopy of proteins has shown that changes in the 
secondary structure, due to environmental, mechanical, or chemical 
stresses, will be reflected in the amide III and amide I bands(Morris 
2011). These alterations may be observed as changes in band position, 
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band area ratio, or band intensity ratio. 
The value of the amide I to amide III ratio was expected to remain 
consistent, regardless of the type of tissue examined. Nevertheless, the 
observed difference clearly supports and extends earlier 
observations(Morris 2011)  that Raman spectroscopy is able to identify 
collagen disorders. Therefore, amide I and amide III Raman bands can 
be used to identify and possibly quantify disorders in the secondary 
structure of collagen protein in osteoarthritic tissue. 
Loss of collagen fiber elasticity from normal ageing could be the 
cause of the spectroscopic changes that are observed in the amide I 
and amide III bands. However in our cohort OA samples had similar 
ages with the normal cadaveric samples and yet there was statistically 
significant difference in the amide ratio between these two groups. 
 
5.2.3 Multivariate Analysis 
PCA and PCA-LDA were used to try and determine if there were 
differences between non-OA and OA specimens across the whole 
spectrum, as well as at a priori bands.  
When comparing OA to control (fresh and cadaveric together), 
irrespective of compartment, two distinct groups form. This is consistent 
with OA being a whole joint disease, something that has been implied 
by the results of the univariate analysis so far.  
Furthermore, if we divide the control group to control fresh and 
control cadaveric (age-matched to OA) again we can easily identify 
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three groups with some degree of overlapping between the OA and 
control fresh group. An attractive explanation for this would be that the 
control cadaveric group, being older has not so far developed clinical 
OA and likely would not do so. Instead the younger, control fresh group, 
may be predisposed to OA and the subtle changes in the subchondral 
bone that reflect this predisposition may well be detected by Raman. 
The changes observed between the non-OA and OA specimens 
using multivariate analysis, both with specimens divided into medial and 
lateral compartments as well as analysed as a whole compartment, in 
combination with the findings from the univariate analysis have shown 
that the whole joint is affected, and perhaps at different stages of 
disease. Multivariate analysis has shown that the main differences are 
due to phosphate and Amide I. This suggests that there are changes in 
collagen, specifically affecting mineralisation of the subchondral bone. 
 
5.2.4 Summary for Raman Spectroscopy Results and Wider 
Implications  
OA tibial plateaus (irrespective of compartment) did demonstrate 
higher phosphate to amide ratio (higher mineralization), lower carbonate 
to phosphate ratio (higher mineralization), higher carbonate to amide I 
ratio (higher remodeling), higher amide I to amide III ratio (alterations in 
collagen structure) when compared to control groups. 
Comparison of the medial to the lateral tibial plateau in OA 
specimens did not demonstrate any statistically significant difference for 
phosphate to amide I ratio, carbonate to phosphate ratio, carbonate to 
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amide I ratio and amide I to amide III ratio. This is not consistent with the 
macroscopic, clinical findings of cartilage loss affecting the medial tibial 
plateau with relative preservation of the lateral compartment. This 
discrepancy could be explained by the notion that osteoarthritis is 
indeed a whole joint disease affecting equally the subchondral bone in 
both medial and lateral compartments but with clinical disease becoming 
apparent first in the main load bearing part of the joint (i.e. medial side).  
 
5.3 Collagen Alpha Chain Analysis  
 
5.3.1 Appraisal of Collagen Alpha Chain Analysis 
 
5.3.1.1 Tissue Preparation 
Pepsin was used to digest proteins and liberate collagen. In reality, 
pepsin does not digest all non-collagenous proteins. This means that 
collagen which was still locked in the matrix after pepsin treatment, was 
lost from the sample when the pellet was discarded. It is widely 
documented that tropocollagen is highly resistant to digestion from most 
proteases with the exception of collagenases(Bannister 1972). However, 
it has been reported that subtle differences occur to tropocollagen after 
treatment with pepsin; such as the release of telopeptide regions which 
are critical for crosslinking α chains(Steven 1965). 
 
 
5.3.1.2 SDS PAGE 
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 The majority of OA samples stained quite well whereas the 
majority of the normal samples failed to stain. It may be that the OA 
samples, because of their superior turnover rate, dissolve more readily 
in pepsin. Perhaps the normal samples could have been left in pepsin 
for longer but this would be a risky strategy. On the other hand, more 
concentrated solutions could have been made by dissolving in less 
sample buffer, or a greater volume could have been loaded onto the 
gels. Either would have increased the quantity of collagen loaded. 
However, increasing the concentration or volume also increases the risk 
of overloading the gel. In hindsight, almost all of the normal samples 
failed to stain whilst at the same concentration and volume as OA 
sample. This strongly suggests that the problem was not the 
concentration or volume used but the solubility of the normal 
collagenous proteins in pepsin. A final criticism of the methodology is 
that the G-force, which is critical to centrifugation, should have also 
been assessed in addition to the speed, time and temperature. 
 
5.3.2 Discussion of Collagen Alpha Chain Analysis Method 
The difference in the α1-chain to α2-chain ratio between OA and 
normal samples was found to be statistically significant. A normal type I 
collagen heterotrimer consists of two α1-chains and one α2-chain in the 
triple helix secondary structure. The OA samples had a median α1-chain 
to α2-chain ratio of 3.05:1 (IQR 3.95:1 – 2.4:1), which is above the 
normal level for heterotrimeric collagen of 2:1 (standard 2.476:1). On the 
contrary, Bailey et al. found ratios in the range of 4:1 – 17:1 in OA 
samples(Bailey 2002). One could argue that the amount of homotrimer 
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depends on the severity of OA. However, all ten patients had Grade IV 
OA. In addition Bailey and his coworkers used an area of cancellous 
bone distant to the joint surface for their measurements, which is in 
contrast with the area used in this current study (defined within 3mm 
from the joint surface). Nevertheless, our results suggest that 
homotrimeric collagen is not always present in OA to the extent that was 
initially anticipated. 
The increase in α1-chain to α2-chain ratio detected supports 
previous work (Bailey 2002; Troung 2006; Couchourel 2009). Troung et 
al. investigated bone at a site distant from the active site of the disease, 
whereas Couchourel et al. and Bailey et al., investigated bone from the 
active site of OA and found higher ratios. It was expected that the ratio 
of alpha 1 to alpha 2 chains would be closer to the results of Bailey et al. 
and Couchourel et al. However Bailey et al. obtained cores from femoral 
heads at a location greater than 3 mm from the joint surface, which is 
what has been used in this study as definition of subchondral bone. 
On the other hand the observed increase in the alpha 1 to alpha 2 
ratio may be exaggerated. It is worth noting that the alpha 1 chain is 139 
kDa whilst the alpha 2 chain is 129kDa. The larger weight of the alpha 1 
chain may cause the band to appear larger than it actually is. This would 
make the ratio higher; and this also may be the reason that the mean 
collagen standard ratio is 2.476:1 rather than the expected 2:1.  
 
 
5.3.3 Summary of Collagen Alpha Chain Analysis and Wider 
Implications 
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This is the first report of an increase in the ratio of alpha 1 to alpha 
2 collagen I chain ratio in subchondral bone from human osteoarthritic 
knees. Collagen I homotrimer has been previously been reported for the 
hip joint. Our samples reflect true subchondral bone and this finding can 
an extra piece in the interpretation of the pathophysiological changes 
associated with OA as well as potentially forming a therapeutic target in 
the future. 
 
5.4 OA IS A WHOLE JOINT DISEASE 
Raman spectroscopy used in this study, found no difference 
between medial and lateral osteoarthritic tibial plateaus. This was 
expected for the control specimens but not for the OA where the medial 
has so clearly advanced grade IV macroscopic disease and the lateral 
does not. These findings suggest that OA of the knee is a total joint 
disease, with the subchondral bone exhibiting chemical changes in the 
entirety of the tibial plateau but with the load-bearing side being 
macroscopically affected first leading to degradation of the articular 
cartilage.  
Furthermore, Raman spectroscopy can detect these changes and 
possibly at an early stage of disease in the subchondral bone, prior to 
cartilage degradation. Future efforts will assess spatially offset Raman 
spectroscopy, a technique offsetting the collection of Raman photons 
and therefore allowing study of materials several millimetres beneath a 
surface (skin), for both characterising and detecting osteoarthritis during 
the early subclinical phase. 
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5.5 CONCLUSIONS 
In summary this study supports the following findings: 
1. OA of the knee is a total joint disease, affecting not only the 
articular cartilage but the underlying subchondral bone as well. 
Chemical alterations in the subchondral bone appear to pre-date 
any cartilage damage and affect both the medial and lateral 
compartments of the knee joint, irrespective of the overlying 
macroscopic degree of cartilage loss. 
2. Raman spectroscopy can detect changes at an early stage of 
clinical disease in the subchondral bone matrix chemistry, prior 
to cartilage degradation. Indeed the differences in OA and non 
OA cohorts may be inherent and allow screening of individuals at 
risk.  
3. subchondral bone has a crucial role in the development of OA. It 
is highly likely that it is the principal tissue involved in the 
aetiopathogenesis of osteoarthritis and therefore an important 
future target for novel diagnostic and therapeutic approaches. 
 
5.6 WIDER IMPLICATIONS 
The findings of this study contribute to the current body of 
knowledge surrounding subchondral bone in OA. The increase in the 
carbonate to amide I ratio in OA specimens may reflect an increase in 
bone turnover. This finding agrees with several previous reports of 
increased turnover in subchondral bone. Perhaps now is the time to ask 
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whether we should start targeting subchondral bone turnover when 
treating OA. This study has further validated Raman Spectroscopy at a 
time where research is entering the translational phase and SORS is 
being considered as a tool for diagnosing bone disorders.  
Can SORS be used to measure mineral to collagen ratio 
differences (and hence mechanical property differences) non-invasively 
in vivo? Can SORS be used to measure amide I band profile changes in 
vivo in diseased or aged bones? A clinical trial of SORS, which looks 
into answering these and other questions, is currently underway at the 
UCL Institute of Orthopaedics and Musculoskeletal Science at the Royal 
National Orthopaedic Hospital (Stanmore). 
 
5.7 FUTURE WORK 
Some of the findings could be correlated with other more 
established techniques. For instance, the hypermineralisation detected 
by Raman spectroscopy could be correlated against levels of 
mineralisation determined through biochemistry. Alternatively, the 
mineral-to-matrix ratio could be calibrated against measured materials 
such as the ash weight of bone. 
Moreover validation of the spectroscopic findings in terms of matrix 
mineralization can be performed in the future by looking at the material 
properties of the subchondral bone. Mechanical properties of bone are a 
combination of bone structure and material properties, where the 
material properties are determined by the chemical composition and 
microstructural organization of the extracellular matrix.   While an 
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increasing level of bone mineralization is accompanied by an increase in 
the stiffness of the bone, it comes at the cost of reduced toughness 
(energy required to cause a fracture) of the bone. In other words, as 
mineralization increases, the tissue becomes more brittle and requires 
less energy to fracture. Therefore, it is possible for a bone that is 
hypermineralized to be more fragile than a bone with a lower degree of 
mineralization. Time unfortunately did not allow testing of the 
mechanical properties of subchondral bone but this investigation is 
currently being undertaken in our laboratory. 
 
5.8 FUTURE DIRECTIONS 
It is intriguing to conceptualize the application of Raman 
spectroscopy as a diagnostic modality given its ease of use, non-
invasiveness and safety. The carbonate to phosphate band area ratio is 
calculated using bands that are not obscured by collagen protein signal. 
Observation of the strong phosphate band at 958 cm-1 and the 
carbonate band at ~1070 cm-1 in spectra that have not been baseline 
corrected indicates that calculation of this ratio would be possible in 
specimens with a thicker articular cartilage layer, therefore allowing 
interrogation of subchondral bone even in those cases where the 
cartilage is not lost due to the osteoarthritic process. Fiber-optic 
technology is frequently used through arthroscopes to evaluate knee, 
hip, shoulder and ankle joints. Silica fiber optic Raman probes have 
been used to evaluate coronary artery calcifications in a clinical 
experimental setting(Brennan 1997), as well as in animal studies to 
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diagnose cellular dysplasia in cancer models(Schut 2000). The non-
destructive nature and sensitivity of Raman spectra to subtle tissue 
changes are attractive features in developing clinically relevant 
platforms such as a fiber-optic insert within an arthroscope. Potentially, 
Raman spectroscopy could be utilized through a combined arthroscopic 
imaging/Raman spectroscopic fiber optic system to diagnose early OA, 
or follow the response of damaged cartilage or subchondral bone to 
therapeutic intervention.  
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